var title_f8_61_9168="Debrunner kyphometer";
var content_f8_61_9168=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F63165&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F63165&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Debrunner kyphometer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 286px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Kado DM, Christianson L, Palermo L, et al. Comparing a supine radiologic versus standing clinical measurement of kyphosis in older women: the Fracture Intervention Trial. Spine 2006; 31:463. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_61_9168=[""].join("\n");
var outline_f8_61_9168=null;
var title_f8_61_9169="Incision rectovaginal fistula";
var content_f8_61_9169=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F81075&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F81075&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Repair of a small rectovaginal fistula through a transvaginal approach",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 365px; height: 433px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An elliptical incision is made about the fistula tract.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_61_9169=[""].join("\n");
var outline_f8_61_9169=null;
var title_f8_61_9170="Pressures aortic stenosis";
var content_f8_61_9170=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F80837&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F80837&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pressures in aortic stenosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 441px; height: 269px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Simultaneously recorded pressures from the left ventricle (LV) and aorta (Ao) in a patient with aortic stenosis. There is a systolic pressure gradient (shaded area) in which the LV systolic pressure is greater than that in the aorta. The pressure gradient and systolic ejection period (SEP, in sec/beat) are used in the Gorlin formula to calculate the aortic valve area (aortic valve area = cardiac output &divide; [44.3 x SEP x HR x sq rt mean gradient]).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Kern MJ (Ed). Cardiac Catheterization Handbook, 2nd ed. Mosby-Year Book, St. Louis, 1995.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_61_9170=[""].join("\n");
var outline_f8_61_9170=null;
var title_f8_61_9171="Chronic HP Light";
var content_f8_61_9171=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F70392&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F70392&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chronic hypersensitivity pneumonitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 287px; height: 185px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph from a patient with chronic hypersensitivity pneumonitis shows a pattern reminiscent of usual interstitial pneumonia. Other areas of the biopsy reveal granulomatous inflammation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Talmadge E King, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_61_9171=[""].join("\n");
var outline_f8_61_9171=null;
var title_f8_61_9172="Extraosseous osteosarcoma with metastatic disease to the lungs";
var content_f8_61_9172=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F83187&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F83187&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 604px\">",
"   <div class=\"ttl\">",
"    Extraosseous osteosarcoma with metastatic disease to the lungs",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 584px; height: 254px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The patient is a 38-year-old female found to have a calcified nodule in the left breast (A, yellow arrow). The CT scan of the chest in the transverse projection reveals&nbsp;three densely calcified nodules in the left lung (B, red arrows). Following surgical excision of the breast mass, pathological evaluation revealed a diagnosis of extraosseous osteosarcoma. The&nbsp;morphological similarity of the lung nodules to the primary tumor on CT suggests metastatic extraosseous osteosarcoma to the lungs.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard Waite, MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_61_9172=[""].join("\n");
var outline_f8_61_9172=null;
var title_f8_61_9173="Chapter 10A: Acids and bases";
var content_f8_61_9173=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chapter 10A: Acids and bases",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/61/9173/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/61/9173/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/61/9173/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/61/9173/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/61/9173/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/61/9173/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/61/9173/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/61/9173/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 14, 2000.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with the other components of the extracellular fluid, the H+ concentration is maintained within narrow limits. The normal extracellular level of H+ is approximately 40",
"    <span class=\"nowrap\">",
"     nanomol/L",
"    </span>",
"    <span class=\"nowrap\">",
"     (nanomol/L",
"    </span>",
"    equals 10-6",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    roughly one-millionth the millimole per liter concentrations of Na+, K+, Cl-, and HCO3-.",
"   </p>",
"   <p>",
"    The regulation of the H+ concentration at this low level is essential for normal cellular function, because of the high reactivity of H+ ions, particularly with proteins [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9173/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. This property is related to the relatively small size of hydronium ions, the hydrated form of H+,&dagger; in comparison with that of Na+ and K+ ions. As a result, H+ ions are more strongly attracted to negatively charged portions of molecules and are more tightly bound than Na+ or K+. When there is a change in the H+ concentration, proteins gain or lose H+ ions, resulting in alterations in charge distribution, molecular configuration, and consequently in protein function. For example, the rate of glycolysis (as measured by the rate of lactate production) varies inversely with the H+ concentration, increasing as the latter is reduced (",
"    <a class=\"graphic graphic_figure graphicRef67433 \" href=\"UTD.htm?31/58/32685\">",
"     figure 1",
"    </a>",
"    ). This change in cellular metabolism is mediated by a similar inverse relationship between the H+ concentration and the activity of several glycolytic enzymes, particularly phosphofructokinase [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9173/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &nbsp;&dagger; In the aqueous environment in the body, H+ ions combine with H2O and exist primarily as hydronium ions, H3O+. For simplicity, H+ will be used in place of H3O+ for the remainder of this discussion.",
"   </p>",
"   <p>",
"    Under normal conditions, the H+ concentration varies little from the normal value of approximately 40",
"    <span class=\"nowrap\">",
"     nanomol/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9173/abstract/3\">",
"     3",
"    </a>",
"    ]. This occurs even though acids and bases are continually being added to the extracellular fluid. The process of H+ regulation involves three basic steps:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Chemical buffering by the extracellular and intracellular buffers.",
"     </li>",
"     <li>",
"      Control of the partial pressure of carbon dioxide in the blood by alterations in the rate of alveolar ventilation.",
"     </li>",
"     <li>",
"      Control of the plasma bicarbonate concentration by changes in renal H+ excretion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This chapter will review the basic principles of acid-base physiology, including the efficacy of buffers in preventing large changes in the H+ concentration. The roles of ventilation and renal H+ excretion in acid-base homeostasis will be discussed in Chap. 11. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12762?source=see_link\">",
"     \"Chapter 11A: Renal hydrogen excretion\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ACIDS AND BASES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Using the definitions proposed by Bronsted, an acid is a substance that can donate H+ ions and a base is a substance that can accept H+ ions [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9173/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. These properties are independent of charge. Thus, H2CO3, HCl, NH4+, and H2PO4- all can act as acids:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;H2CO3 &nbsp; &nbsp;&lt;-&gt; &nbsp; &nbsp;H+ &nbsp;+ &nbsp;HCO3-",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;HCl &nbsp; &lt;-&gt; &nbsp; &nbsp;H+ &nbsp;+ &nbsp;Cl-",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;NH4+ &nbsp; &nbsp;&lt;-&gt; &nbsp; &nbsp;H+ &nbsp;+ &nbsp;NH3",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;H2PO4- &nbsp; &lt;-&gt; &nbsp; H+ &nbsp;+ &nbsp;HPO42-",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;Acid &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Base",
"   </p>",
"   <p>",
"    There are two classes of acids that are physiologically important: carbonic acid (H2CO3) and noncarbonic acids. This distinction is important because of the different rates of production and routes of elimination of these acids. Each day, the metabolism of carbohydrates and fats results in the generation of approximately 15,000 mmol of CO2. Although CO2 is not an acid, it combines with water to form H2CO3 (see below). Thus, there would be progressive accumulation of acid if the endogenously produced CO2 were not excreted. This is prevented by the loss of CO2 via respiration.",
"   </p>",
"   <p>",
"    Noncarbonic acids, in comparison, are primarily derived from the metabolism of proteins. As an example, the oxidation of sulfur-containing amino acids results in the generation of H2SO4 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9173/abstract/6\">",
"     6",
"    </a>",
"    ]. Only 50 to 100",
"    <span class=\"nowrap\">",
"     meq/day",
"    </span>",
"    of acid is produced from these sources [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9173/abstract/3,6\">",
"     3,6",
"    </a>",
"    ]; these H+ ions are then excreted in the urine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     LAW OF MASS ACTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The law of mass action states that the velocity of a reaction is proportional to the product of the concentrations of the reactants. For example, water can dissociate into hydrogen and hydroxyl ions&dagger;:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;H2O &nbsp; &lt;-&gt; &nbsp; H+ &nbsp; + &nbsp; OH-",
"   </p>",
"   <p>",
"    &nbsp;&dagger; This reaction actually should be written &nbsp;- &nbsp;H2O &nbsp;+ &nbsp;H2O &nbsp; &lt;-&gt; &nbsp; H3O+ &nbsp; + &nbsp;OH-",
"   </p>",
"   <p>",
"    The velocity with which this reaction moves to the right is equal to",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;v1 &nbsp; &nbsp; = &nbsp; &nbsp;k1 [H2O]",
"   </p>",
"   <p>",
"    where k1 &nbsp;is the rate constant for this reaction. Similarly, the velocity with which the reaction moves to the left can be expressed by",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;v2 &nbsp; &nbsp; = &nbsp; &nbsp;k2 [H+] [OH-]",
"   </p>",
"   <p>",
"    At equilibrium, v1 = v2. Therefore,",
"   </p>",
"   <p>",
"    (Eq. 1) &nbsp; &nbsp;k1 [H2O] &nbsp; = &nbsp; k2 [H+] [OH-]",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; k1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;[H+] [OH-]",
"    <br/>",
"    &nbsp; &nbsp;K ' &nbsp; = &nbsp; &nbsp;- &nbsp; &nbsp; &nbsp; = &nbsp; &nbsp; &mdash;&mdash;&mdash;&mdash;&mdash;&mdash;",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; k2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [H2O]",
"   </p>",
"   <p>",
"    Since the H2O concentration is relatively constant in the body fluids, this equation can be rearranged so that,",
"   </p>",
"   <p>",
"    (Eq. 2) &nbsp; &nbsp;Kw &nbsp; &nbsp;= &nbsp; &nbsp; &nbsp;[H+] [OH-]",
"   </p>",
"   <p>",
"    where Kw is equal to the product of the two constants, K ' and [H2O]. At body temperature, Kw &nbsp; = &nbsp; 2.4 &nbsp;x &nbsp;10-14. Thus, for distilled water,",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;[H+] [OH-] &nbsp; &nbsp;= &nbsp; &nbsp; &nbsp;2.4 &nbsp;x &nbsp;10-14",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;[H+] &nbsp; &nbsp;= &nbsp; &nbsp; 1.55 &nbsp;x &nbsp;10-7",
"    <span class=\"nowrap\">",
"     mol/L",
"    </span>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;[OH-] &nbsp; &nbsp;= &nbsp; &nbsp; 1.55 &nbsp;x &nbsp;10-7",
"    <span class=\"nowrap\">",
"     mol/L",
"    </span>",
"   </p>",
"   <p>",
"    Since the normal H+ concentration &nbsp;the extracellular fluid is 40",
"    <span class=\"nowrap\">",
"     nanomol/L,",
"    </span>",
"    we can see that the extracellular fluid is slightly less acid than water (where the H+ concentration is 155",
"    <span class=\"nowrap\">",
"     nanomol/L).",
"    </span>",
"   </p>",
"   <p>",
"    The law of mass action can be written for the dissociation of all the acids and bases in the body. For example, for the dissociation of an acid HA into H+ + A-,",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [H+] [A-]",
"    <br/>",
"    (Eq. 3) &nbsp; &nbsp;Ka &nbsp; &nbsp;= &nbsp; &nbsp; &nbsp;&mdash;&mdash;&mdash;&mdash;",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [HA]",
"   </p>",
"   <p>",
"    where Ka is the apparent ionization or dissociation constant for this acid. In the body, Ka has a single value for the dissociation of each acid. Although the Ka &nbsp;can vary slightly with changes in temperature, solute concentration, and H+ concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9173/abstract/7,8\">",
"     7,8",
"    </a>",
"    ], these parameters are held relatively constant under normal conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9173/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Since the same principles can be applied to the dissociation of a base,",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;BOH &nbsp; &lt;-&gt; &nbsp; B+ &nbsp;+ &nbsp;OH-",
"   </p>",
"   <p>",
"    the behavior of bases will not be discussed separately [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9173/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acids and bases may be strong or weak. Strong acids are those which are essentially completely ionized in the body. Since most of the acid exists as H+ and A-, a strong acid, from Eq. (3), has a relatively high Ka. HCl and NaOH are examples of a strong acid and a strong base. In comparison, H2PO4- is only 80 percent dissociated at the normal extracellular H+ concentration and is considered a weak acid. As we will see, weak acids are the principal buffers in the body.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32668733\">",
"    <span class=\"h1\">",
"     PH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pH of a solution can be defined by the following relationship:",
"   </p>",
"   <p>",
"    (Eq. 4) &nbsp; &nbsp;pH &nbsp; = &nbsp; &nbsp; -log [H+]",
"   </p>",
"   <p>",
"    In the laboratory, the H+ concentration of the blood is measured with a glass membrane electrode which is permeable only to H+. The diffusion of H+ ions between the blood and the fluid in the electrode results in the generation of a measurable electrical potential (Em) across the membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9173/abstract/9\">",
"     9",
"    </a>",
"    ]. The magnitude of this potential is proportional to the logarithm of the ratio of the H+ concentration in the two compartments according to the Nernst equation:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;[H+]e",
"    <br/>",
"    &nbsp; &nbsp;Em &nbsp; = &nbsp; &nbsp; 61 log &nbsp;&mdash;&mdash;&mdash;",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;[H+]b",
"   </p>",
"   <p>",
"    where the subscripts e and b refer to the fluid within the electrode and the blood, respectively. Since [H+]e &nbsp;is a known value,",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 1",
"    <br/>",
"    &nbsp; &nbsp;Em &nbsp; &nbsp;~ &nbsp; &nbsp;log &nbsp;&mdash;&mdash;&mdash;&mdash;",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [H+]b",
"   </p>",
"   <p>",
"    The log",
"    <span class=\"nowrap\">",
"     (1/a)",
"    </span>",
"    is equal to - log a. Therefore,",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;Em &nbsp; &nbsp;~ &nbsp; &nbsp;- log [H+]b",
"   </p>",
"   <p>",
"    Since pH &nbsp;= &nbsp;- log [H+],",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;Em &nbsp; &nbsp;~ &nbsp; &nbsp;pH&dagger;",
"   </p>",
"   <p>",
"    &dagger; The membrane potential and the pH are actually proportional to the activity of H+, that is, to the random movement of H+ across the membrane, not to its molar concentration. Although the activity of H+ (aH+) is directly proportional to the H+ concentration,",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;aH+ &nbsp; = &nbsp; g [H+]",
"   </p>",
"   <p>",
"    the value of g is dependent upon the ionic strength of the solution. In concentrated ionic solutions, ionic interaction between H+ and anions can retard the random movement of H+ so that its activity is significantly less than its concentration. However, the body fluids are relatively dilute, and it can be assumed without much error that g is equal to 1 and therefore that the aH+ is equal to the H+ concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9173/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is important to note that the pH varies inversely with the H+ concentration. Thus, an increase in the H+ concentration reduces the pH, and a decrease in the H+ concentration elevates the pH. The relationship between the H+ concentration and pH within the physiologic range is depicted in Table 1 (",
"    <a class=\"graphic graphic_figure graphicRef68879 \" href=\"UTD.htm?41/5/42077\">",
"     figure 2",
"    </a>",
"    ). In general, the range of H+ concentration that is compatible with life is 16 to 160",
"    <span class=\"nowrap\">",
"     nanomol/L",
"    </span>",
"    (pH equals 7.80 to 6.80). The normal arterial pH is approximately 7.40; thus, the normal H+ concentration can be calculated from:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;pH &nbsp; = &nbsp; - log [H+]",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;log [H+] &nbsp; = &nbsp; - 7.40",
"   </p>",
"   <p>",
"    Taking the antilogarithm of both sides,",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;[H+] &nbsp; = &nbsp; antilog (- 7.40) &nbsp; &nbsp;= &nbsp; antilog (0.60 &nbsp; &nbsp;- &nbsp; 8)",
"   </p>",
"   <p>",
"    The antilogarithm of 0.60 is 4, that of -8 is 10-8. Therefore,",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;[H+] &nbsp; = &nbsp; &nbsp; 4 &nbsp;x &nbsp;10-8",
"    <span class=\"nowrap\">",
"     mol/L",
"    </span>",
"    &nbsp; = &nbsp; 40",
"    <span class=\"nowrap\">",
"     nanomol/L",
"    </span>",
"   </p>",
"   <p>",
"    The relative merits of measuring the acidity of a solution in terms of pH or H+ concentration have been the subject of much debate [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9173/abstract/11\">",
"     11",
"    </a>",
"    ]. Since this issue is not likely to be important in the clinical setting, &nbsp;the following discussion will use both pH and H+ concentration to familiarize the reader with these concepts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     HENDERSON-HASSELBALCH EQUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Equation 3 can be rearranged in the following manner:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [HA]",
"    <br/>",
"    (Eq. 5) &nbsp; &nbsp;[H+] &nbsp; = &nbsp; &nbsp; Ka &nbsp; &mdash;&mdash;",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [A-]",
"   </p>",
"   <p>",
"    If we take the negative logarithm of both sides,",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [HA]",
"    <br/>",
"    &nbsp; &nbsp;- log [H+] &nbsp; = &nbsp; &nbsp; - log Ka &nbsp;- &nbsp;log &nbsp;&mdash;&mdash;",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [A-]",
"   </p>",
"   <p>",
"    Substituting pH for - log [H+], + log ([A-]",
"    <span class=\"nowrap\">",
"     /",
"    </span>",
"    [HA]) for - log ([HA]",
"    <span class=\"nowrap\">",
"     /",
"    </span>",
"    [A-]), and defining pKa &nbsp;as - log Ka (the H+ concentration and Ka being expressed in units of moles per liter),",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [A-]",
"    <br/>",
"    (Eq. 6) &nbsp; &nbsp;pH &nbsp; = &nbsp; &nbsp; pKa &nbsp;+ &nbsp;log &nbsp;&mdash;&mdash;",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [HA]",
"   </p>",
"   <p>",
"    This is the Henderson-Hasselbalch equation, which can be written for the dissociation of any weak acid. Using the Bronsted definition, in which A- acts as a base and HA as an acid, this equation becomes",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; base",
"    <br/>",
"    (Eq. 7) &nbsp; &nbsp;pH &nbsp; = &nbsp; &nbsp; pKa &nbsp;+ &nbsp;log &nbsp;&mdash;&mdash;&mdash;",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; acid",
"   </p>",
"   <p>",
"    For example, for the reaction",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;H2PO4- &nbsp; &nbsp; &lt;-&gt; &nbsp; &nbsp; &nbsp;H+ &nbsp;+ &nbsp;HPO4(2-)",
"   </p>",
"   <p>",
"    the relationship between the concentrations of the reactants can be expressed either by the law of mass action or by the Henderson-Hasselbalch equation:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;[H2PO4-]",
"    <br/>",
"    (Eq. 8) &nbsp; &nbsp;[H+] &nbsp; = &nbsp; Ka &nbsp;&mdash;&mdash;&mdash;&mdash;&mdash;",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;[HPO4(2-)]",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [HPO4(2-)]",
"    <br/>",
"    (Eq. 9) &nbsp; &nbsp;pH &nbsp; = &nbsp; &nbsp; pKa &nbsp;+ &nbsp;log &nbsp;&mdash;&mdash;&mdash;&mdash;&mdash;",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;[H2PO4-]",
"   </p>",
"   <p>",
"    The Ka &nbsp;for this reaction is 1.6 &nbsp;x &nbsp;10-7",
"    <span class=\"nowrap\">",
"     mol/L",
"    </span>",
"    (or 160",
"    <span class=\"nowrap\">",
"     nanomol/L)",
"    </span>",
"    and the pKa &nbsp;is 6.80.",
"   </p>",
"   <p>",
"    To show how these equations can be used, let us calculate the HPO4(2-)and H2PO4- &nbsp;concentrations in the extracellular fluid if the total phosphate concentration is 1",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    and the H+ concentration equals 40",
"    <span class=\"nowrap\">",
"     nanomol/L",
"    </span>",
"    (pH is 7.40). From the law of mass action,",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [H2PO4-]",
"    <br/>",
"    &nbsp; &nbsp;40 &nbsp; = &nbsp; &nbsp; 160 &nbsp;&mdash;&mdash;&mdash;&mdash;&mdash;",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [HPO4(2-)",
"    <br/>",
"    or",
"   </p>",
"   <p>",
"    &nbsp; [HPO4(2-)]",
"    <br/>",
"    &nbsp; &mdash;&mdash;&mdash;&mdash;&mdash; &nbsp; = &nbsp; 4",
"    <br/>",
"    &nbsp; &nbsp;[H2PO4-]",
"   </p>",
"   <p>",
"    Since the total phosphate concentration is 1",
"    <span class=\"nowrap\">",
"     mmol/L,",
"    </span>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;[HPO4(2-)] &nbsp; = &nbsp; &nbsp; 0.8",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;[H2PO4-] &nbsp; = &nbsp; &nbsp; 0.2",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"   </p>",
"   <p>",
"    The same results can be obtained from the Henderson-Hasselbalch equation:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;[HPO4(2-)]",
"    <br/>",
"    &nbsp; &nbsp;7.40 &nbsp; = &nbsp; &nbsp; 6.80 &nbsp;+ &nbsp;log &nbsp;&mdash;&mdash;&mdash;&mdash;&mdash;",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [H2PO4-]",
"   </p>",
"   <p>",
"    Since the antilogarithm of 0.60 (7.40 &nbsp;- &nbsp;6.80) is 4,",
"   </p>",
"   <p>",
"    &nbsp; [HPO4(2-)]",
"    <br/>",
"    &nbsp; &mdash;&mdash;&mdash;&mdash;&mdash; &nbsp; = &nbsp; 4",
"    <br/>",
"    &nbsp; &nbsp;[H2PO4-]",
"   </p>",
"   <p>",
"    It should be noted that phosphate also can exist as PO43- and H3PO4:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;3",
"    <br/>",
"    &nbsp; &nbsp;PO4(3-) &nbsp;+ &nbsp;H+ &nbsp; &nbsp;&lt;-&gt; &nbsp; &nbsp;HPO4(2-) &nbsp;+ &nbsp;H+ &nbsp; &nbsp;&lt;-&gt; &nbsp; &nbsp;H2PO4- &nbsp;+ &nbsp;H+ &nbsp; &nbsp;&lt;-&gt; &nbsp; &nbsp;H3PO4",
"   </p>",
"   <p>",
"    However, only trace amounts of PO4(3-) and H3PO4 are present in the body since the pKa &nbsp;of reaction 1 (pKa1 &nbsp;= &nbsp;12.4) is much higher and that of reaction 3 (pKa3 &nbsp;= &nbsp;2.0) is much lower than the extracellular pH of 7.40. For example, for reaction 1,",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;[PO4(3-)]",
"    <br/>",
"    &nbsp; &nbsp;7.40 &nbsp; = &nbsp; &nbsp; 12.40 &nbsp;+ &nbsp;log &nbsp;&mdash;&mdash;&mdash;&mdash;&mdash;",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;[HPO4(2-)]",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;[PO4(3-)]",
"    <br/>",
"    &nbsp; &nbsp; &mdash;&mdash;&mdash;&mdash;&mdash; &nbsp; = &nbsp; antilog (- 5) &nbsp; = &nbsp; 10(-5)",
"    <br/>",
"    &nbsp; &nbsp; [HPO4(2-)]",
"   </p>",
"   <p>",
"    Thus, at pH of 7.40, there is only one molecule of PO4(3-)present for every 105 molecules of HPO4(2-).",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/43/23224?source=see_link\">",
"     \"Chapter 10B: Buffers\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    (From Rose, BD, Post, TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York, 2001.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9173/abstract/1\">",
"      Relman AS. Metabolic consequences of acid-base disorders. Kidney Int 1972; 1:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9173/abstract/2\">",
"      Ganapathy V, Leibach FH. Protons and regulation of biological functions. Kidney Int Suppl 1991; 33:S4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9173/abstract/3\">",
"      Kurtz I, Maher T, Hulter HN, et al. Effect of diet on plasma acid-base composition in normal humans. Kidney Int 1983; 24:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9173/abstract/4\">",
"      RELMAN AS. What are acids and bases? Am J Med 1954; 17:435.",
"     </a>",
"    </li>",
"    <li>",
"     Madias, NE, Cohen, JJ. Acid-base chemistry and buffering. In: Acid / Base, Cohen JJ, Kassirer JP (Ed), Little, Brown, Boston, 1982, pp.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9173/abstract/6\">",
"      Lennon EJ, Lemann J Jr, Litzow JR. The effects of diet and stool composition on the net external acid balance of normal subjects. J Clin Invest 1966; 45:1601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9173/abstract/7\">",
"      Hood I, Campbell EJ. Sounding Boards. Is pK OK? N Engl J Med 1982; 306:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9173/abstract/8\">",
"      Kruse JA, Hukku P, Carlson RW. Relationship between the apparent dissociation constant of blood carbonic acid and severity of illness. J Lab Clin Med 1989; 114:568.",
"     </a>",
"    </li>",
"    <li>",
"     Gennari, FJ, Cohen, JJ, Kassirer, JP. Measurement of acid-base status. In: Acid / Base, Cohen JJ, Kassirer JP (Ed), Little, Brown, Boston, 1982, pp.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9173/abstract/10\">",
"      Pitts, RF. Physiology of the Kidney and Body Fluids. Year Book, Chicago 1974; :chap 11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9173/abstract/11\">",
"      Hills AG. pH and the Henderson-Hasselbalch equation. Am J Med 1973; 55:131.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7260 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.131.240.2-13CD9D8202-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_61_9173=[""].join("\n");
var outline_f8_61_9173=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ACIDS AND BASES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      LAW OF MASS ACTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32668733\">",
"      PH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      HENDERSON-HASSELBALCH EQUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7260\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7260|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/58/32685\" title=\"figure 1\">",
"      Lactate production in WBC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/5/42077\" title=\"figure 2\">",
"      pH and H concentration",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/43/23224?source=related_link\">",
"      Chapter 10B: Buffers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12762?source=related_link\">",
"      Chapter 11A: Renal hydrogen excretion",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_61_9174="Folic acid: Drug information";
var content_f8_61_9174=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Folic acid: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?24/57/25492?source=see_link\">",
"    see \"Folic acid: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/31/22005?source=see_link\">",
"    see \"Folic acid: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F6813283\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Folacin-800 [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F173692\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Folic&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F173733\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Vitamin, Water Soluble",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F173695\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Anemia:",
"     </b>",
"     Oral, I.M., I.V., SubQ: 0.4 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Pregnant and lactating women: 0.8 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Recommended daily allowance (RDA)",
"     </b>",
"     (IOM, 1998): Expressed as dietary folate equivalents: Oral: 400 mcg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Pregnancy: 600 mcg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lactation: 500 mcg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Prevention of neural tube defects:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Females of childbearing potential: 400-800 mcg/day (USPSTF, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Females at high risk or with family history of neural tube defects: 4 mg/day (ACOG, 2003)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F173716\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/31/22005?source=see_link\">",
"      see \"Folic acid: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Anemia:",
"     </b>",
"     Oral, I.M., I.V., SubQ:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants: 0.1 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &lt;4 years: Up to 0.3 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &gt;4 years and Adults: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Adequate intake (AI)",
"     </b>",
"     (IOM, 1998): Expressed as folate equivalents: Oral: Infants:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1-6 months: 65 mcg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     7-12 months: 80 mcg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Recommended daily allowance (RDA)",
"     </b>",
"     (IOM, 1998): Expressed as dietary folate equivalents: Oral: Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1-3 years: 150 mcg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4-8 years: 200 mcg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     9-13 years: 300 mcg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &ge;14 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F173696\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing. Vitamin B",
"     <sub>",
"      12",
"     </sub>",
"     deficiency must be ruled out before initiating folate therapy due to frequency of combined nutritional deficiencies: RDA requirements (1999): 400 mcg/day (0.4 mg) minimum.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F173671\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as sodium folate: 5 mg/mL (10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 0.4 mg, 0.8 mg, 1 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Folacin-800: 0.8 mg [scored; gluten free, sugar free]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F173657\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F173675\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral preferred, but may also be administered by deep I.M., SubQ, or I.V. injection.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.V. administration: May administer &le;5 mg dose undiluted over &ge;1 minute",
"     <b>",
"      or",
"     </b>",
"     may dilute &le;5 mg in 50 mL of NS or D",
"     <sub>",
"      5",
"     </sub>",
"     W and infuse over 30 minutes. May also be added to I.V. maintenance solutions and given as an infusion.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F173739\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      20",
"     </sub>",
"     W, NS, fat emulsion 10%;",
"     <b>",
"      incompatible",
"     </b>",
"     with D",
"     <sub>",
"      40",
"     </sub>",
"     W, D",
"     <sub>",
"      50",
"     </sub>",
"     W. Do not use with oxidizing and reducing agents or heavy metal ions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Famotidine.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Incompatible:",
"     </b>",
"     Doxapram.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Magnesium sulfate.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F173674\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of megaloblastic and macrocytic anemias due to folate deficiency; dietary supplement to prevent neural tube defects",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F5223515\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjunctive cofactor therapy in methanol toxicity (alternative to leucovorin calcium)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F173740\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Folic acid may be confused with folinic acid",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F173731\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Flushing (slight)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Malaise (general)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Erythema, pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchospasm",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reaction",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F173679\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to folic acid or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F173661\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anemia: Monotherapy: Not appropriate for monotherapy with pernicious, aplastic, or normocytic anemias when anemia is present with vitamin B",
"     <sub>",
"      12",
"     </sub>",
"     deficiency.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pernicious anemia: Doses &gt;0.1 mg/day may obscure pernicious anemia with continuing irreversible nerve damage progression.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Benzyl alcohol: Injection contains benzyl alcohol (1.5%) as preservative which has been associated with \"gasping syndrome\" in neonates.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Resistance to treatment: May occur with depressed hematopoiesis, alcoholism, and deficiencies of other vitamins.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299358\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F173665\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: Folic Acid may decrease the serum concentration of Fosphenytoin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Green Tea: May decrease the serum concentration of Folic Acid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PHENobarbital: Folic Acid may decrease the serum concentration of PHENobarbital.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: Folic Acid may decrease the serum concentration of Phenytoin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Primidone: Folic Acid may decrease the serum concentration of Primidone. Additionally, folic acid may decrease concentrations of active metabolites of primidone (e.g., phenobarbital).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Raltitrexed: Folic Acid may diminish the therapeutic effect of Raltitrexed.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F173668\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F173683\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Water soluble vitamins cross the placenta. Folate requirements increase during pregnancy. Folate supplementation during the periconceptual period decreases the risk of neural tube defects. Folate supplementation (doses larger than the RDA) is recommended for women who may become pregnant (IOM, 1998).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F173700\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/compatible",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F14191848\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Folate is found in breast milk; concentrations are not affected by dietary intake unless the mother has a severe deficiency (IOM, 1998).",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F173684\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     As of January 1998, the FDA has required manufacturers of enriched flour, bread, corn meal, pasta, rice, and other grain products to add folic acid to their products. The intent is to help decrease the risk of neural tube defects by increasing folic acid intake. Other foods which contain folic acid include dark green leafy vegetables, citrus fruits and juices, and lentils.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F173682\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Folic Acid Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (100): $7.20",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (100): $8.40",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Folic Acid Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg/mL (10 mL): $25.63",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (FA-8 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     800 mcg (100): $3.78",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Folic Acid Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 mg (100): $35.99",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     400 mcg (250): $3.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     800 mcg (100): $2.55",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F173672\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Therapeutic: 0.005-0.015 mcg/mL",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F173685\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      A.F. Valdecasas (MX);",
"     </li>",
"     <li>",
"      Acfol (ES, PT);",
"     </li>",
"     <li>",
"      Acide Folique CCD (FR);",
"     </li>",
"     <li>",
"      Acido Folico (AR, CO, EC, PE);",
"     </li>",
"     <li>",
"      Acido Folico Fada (AR);",
"     </li>",
"     <li>",
"      Acifol (AR);",
"     </li>",
"     <li>",
"      Apo-Folic (NZ);",
"     </li>",
"     <li>",
"      Bio-Folic (BE);",
"     </li>",
"     <li>",
"      Conacid (AR);",
"     </li>",
"     <li>",
"      Elvefocal (AR);",
"     </li>",
"     <li>",
"      Endofolin (BR);",
"     </li>",
"     <li>",
"      Enhansid (PH);",
"     </li>",
"     <li>",
"      Feri (PH);",
"     </li>",
"     <li>",
"      Filicine (GR);",
"     </li>",
"     <li>",
"      Folacid (PL);",
"     </li>",
"     <li>",
"      Folacin (HR, NO, RU, SE, TW);",
"     </li>",
"     <li>",
"      Folart (PH);",
"     </li>",
"     <li>",
"      Folavit (BE);",
"     </li>",
"     <li>",
"      Folbiol (TR);",
"     </li>",
"     <li>",
"      Foliage (PH);",
"     </li>",
"     <li>",
"      Foliamin (HK, JP, TH);",
"     </li>",
"     <li>",
"      Folic Acid DHA (MY);",
"     </li>",
"     <li>",
"      Folic Acid Pharm Ecologist (AR);",
"     </li>",
"     <li>",
"      Folicid (KP);",
"     </li>",
"     <li>",
"      Folicil (PT);",
"     </li>",
"     <li>",
"      Folimax (PH);",
"     </li>",
"     <li>",
"      Folimet (DK);",
"     </li>",
"     <li>",
"      Folin (BR);",
"     </li>",
"     <li>",
"      Folina (IT);",
"     </li>",
"     <li>",
"      Folinsyre &rdquo;Dak&rdquo; (DK);",
"     </li>",
"     <li>",
"      Foliphar (BE);",
"     </li>",
"     <li>",
"      Folivit (TH);",
"     </li>",
"     <li>",
"      Folivital (GT, HN, MX, NI, SV);",
"     </li>",
"     <li>",
"      Folsan (AT, HR);",
"     </li>",
"     <li>",
"      Folsyre (NO);",
"     </li>",
"     <li>",
"      Folverlan (DE);",
"     </li>",
"     <li>",
"      Folvite (AE, BB, BH, BM, BS, BZ, CH, CY, EG, FI, GY, IL, IQ, IR, JM, JO, KW, LB, LY, NL, OM, QA, SA, SR, SY, TT, YE);",
"     </li>",
"     <li>",
"      Gravi-Fol (DE);",
"     </li>",
"     <li>",
"      Gravida (BE);",
"     </li>",
"     <li>",
"      Huma-Folacid (HU);",
"     </li>",
"     <li>",
"      Ingafol (IN);",
"     </li>",
"     <li>",
"      Lexpec (GB, IE);",
"     </li>",
"     <li>",
"      Megafol (AU);",
"     </li>",
"     <li>",
"      Mithra Folic (BE);",
"     </li>",
"     <li>",
"      Prinac AC (MX);",
"     </li>",
"     <li>",
"      RubieFol (DE);",
"     </li>",
"     <li>",
"      Tecnovorin (BR);",
"     </li>",
"     <li>",
"      Travital Folic Acid (BE);",
"     </li>",
"     <li>",
"      Vifolin (AE, BH, CY, EG, IL, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F173660\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Folic acid is necessary for formation of a number of coenzymes in many metabolic systems, particularly for purine and pyrimidine synthesis; required for nucleoprotein synthesis and maintenance in erythropoiesis; stimulates WBC and platelet production in folate deficiency anemia. Folic acid enhances the metabolism of formic acid, the toxic metabolite of methanol, to nontoxic metabolites (unlabeled use).",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F173678\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Peak effect: Oral: 0.5-1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Proximal part of small intestine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      ACOG Committee on Practice Bulletins, \"ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 44, July 2003. (Replaces Committee Opinion Number 252, March 2001),\"",
"      <i>",
"       Obstet Gynecol",
"      </i>",
"      , 2003, 102(1):203-13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/61/9174/abstract-text/12850637/pubmed\" id=\"12850637\" target=\"_blank\">",
"        12850637",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Barceloux DG, Bond GR, Krenzelok EP, et al, &ldquo;American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Methanol Poisoning,&rdquo;",
"      <i>",
"       J Toxicol Clin Toxicol",
"      </i>",
"      , 2002, 40(4):415-46.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/61/9174/abstract-text/12216995/pubmed\" id=\"12216995\" target=\"_blank\">",
"        12216995",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Davis RE, &ldquo;Clinical Chemistry of Folic Acid,&rdquo;",
"      <i>",
"       Adv Clin Chem",
"      </i>",
"      , 1986, 25:233-94.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/61/9174/abstract-text/3087140/pubmed\" id=\"3087140\" target=\"_blank\">",
"        3087140",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Department of Health and Human Services, Food and Drug Administration, Nutrition Labeling,",
"      <i>",
"       Fed Regist",
"      </i>",
"      , 1980, 45:69043.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      IOM (Institute of Medicine),",
"      <i>",
"       Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B",
"      </i>",
"      <sub>",
"       6",
"      </sub>",
"      <i>",
"       , Folate, Vitamin B",
"      </i>",
"      <sub>",
"       12",
"      </sub>",
"      <i>",
"       , Pantothenic Acid, Biotin and Choline",
"      </i>",
"      , Washington, DC: National Academy Press, 1998.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lambie DG and Johnson RH, &ldquo;Drugs and Folate Metabolism,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1985, 30(2):145-55.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/61/9174/abstract-text/3896745/pubmed\" id=\"3896745\" target=\"_blank\">",
"        3896745",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lange H, Suryapranata H, De Luca G, et al, &ldquo;Folate Therapy and In-Stent Restenosis After Coronary Stenting,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2004, 350(26):2673-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/61/9174/abstract-text/15215483/pubmed\" id=\"15215483\" target=\"_blank\">",
"        15215483",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lewis DP, Van Dyke DC, Willhite LA, et al, &ldquo;Phenytoin-Folic Acid Interaction,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1995, 29(7-8):726-35.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/61/9174/abstract-text/8520091/pubmed\" id=\"8520091\" target=\"_blank\">",
"        8520091",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Liem A, Reynierse-Buitenwerf GH, Zwinderman AH, et al, &ldquo;Secondary Prevention With Folic Acid: Effects on Clinical Outcomes,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2003, 41(12):2105-13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/61/9174/abstract-text/12821232/pubmed\" id=\"12821232\" target=\"_blank\">",
"        12821232",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Olszewski AJ, Szostak WB, Bialkowska M, et al, &ldquo;Reduction of Plasma Lipid and Homocysteine Levels by Pyridoxine, Folate, Cobalamin, Choline, Riboflavin, and Troxerutin in Atherosclerosis,&rdquo;",
"      <i>",
"       Atherosclerosis",
"      </i>",
"      , 1989, 75(1):1-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/61/9174/abstract-text/2930611/pubmed\" id=\"2930611\" target=\"_blank\">",
"        2930611",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Savage DG and Lindenbaum J, &ldquo;Folate-Cobalamin Interactions,&rdquo; Bailey LB, ed,",
"      <i>",
"       Folate in Health and Disease",
"      </i>",
"      , New York: Marcel Dekker, Inc, 1995, 237-85.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schnyder G, Roffi M, Flammer Y, et al, &ldquo;Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Clinical Outcome After Percutaneous Coronary Intervention: The Swiss Heart Study: A Randomized Controlled Trial,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2002, 288(8):973-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/61/9174/abstract-text/12190367/pubmed\" id=\"12190367\" target=\"_blank\">",
"        12190367",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      U.S. Preventive Services Task Force, &ldquo;Folic Acid for the Prevention of Neural Tube Defects: U.S. Preventive Services Task Force Recommendation Statement,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 2009, 150(9):626-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/61/9174/abstract-text/19414842/pubmed\" id=\"19414842\" target=\"_blank\">",
"        19414842",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8475 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-11D65C23BF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_61_9174=[""].join("\n");
var outline_f8_61_9174=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6813283\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173692\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173733\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173695\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173716\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173696\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173671\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173657\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173675\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173739\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173674\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5223515\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173740\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173731\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173679\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173661\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299358\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173665\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173668\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173683\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173700\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14191848\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173684\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173682\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173672\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173685\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173660\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173678\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8475\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8475|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?24/57/25492?source=related_link\">",
"      Folic acid: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/31/22005?source=related_link\">",
"      Folic acid: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_61_9175="Echo in Fabry disease with LVH";
var content_f8_61_9175=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F55283&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F55283&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    Echocardiography in fabry disease with left ventricular hypertrophy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 366px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Two-dimensional echocardiography in four-chamber apical view and left ventricular endomyocardial biopsy from a patient with Fabry disease cardiomyopathy with left ventricular hypertrophy (panels A and C) and from a patient with left ventricular hypertrophy due to hypertrophic cardiomyopathy (panels B and D). Panel A shows two major findings: a thickened hyperechogenic layer, which represents intracellular glycosphingolipid deposition in the endocardium (End) and subendocardial myocardium (SM) (panel C); and a hypoechogenic middle layer (ML) of the myocardium that appears partially spared. This echocardiographic pattern is absent in hypertrophic cardiomyopathy (panel B), despite a similar thickening of the endocardium (panel D).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from Pieroni M, Chimenti C, De Cobelli F, et al. J Am Coll Cardiol 2006; 47:1663. Copyright &copy; 2006 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_61_9175=[""].join("\n");
var outline_f8_61_9175=null;
var title_f8_61_9176="Management of the difficult-to-wean patient";
var content_f8_61_9176=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of the difficult-to-wean patient",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/61/9176/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/61/9176/contributors\">",
"     Scott K Epstein, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/61/9176/contributors\">",
"     Martin F Joyce-Brady, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/61/9176/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/61/9176/contributors\">",
"     Polly E Parsons, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/61/9176/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/61/9176/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/61/9176/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 25, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients are considered to have undergone simple weaning if they pass their first spontaneous breathing trial (SBT). They are considered difficult-to-wean if they fail their first SBT and then require up to three SBTs or seven days to pass a SBT. Finally, patients are considered to have undergone prolonged weaning if they fail at least three SBTs or require more than seven days to pass a SBT [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who are difficult-to-wean are common. In a prospective cohort study of 257 medical and surgical patients in whom weaning was attempted, the incidences of simple, difficult, and prolonged weaning were 59, 26, and 14 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/2\">",
"     2",
"    </a>",
"    ]. Similarly, another prospective cohort study of 2714 patients mechanically ventilated for &gt;12 hours found that the incidences of simple, difficult, and prolonged weaning were 55, 39, and 6 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/3\">",
"     3",
"    </a>",
"    ]. Patients who required more than seven days to wean were found to be at increased risk for death.",
"   </p>",
"   <p>",
"    The management of patients who are difficult-to-wean is reviewed here. Patients who undergo prolonged weaning",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    require prolonged mechanical ventilation require more sophisticated management strategies, which are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37673?source=see_link\">",
"     \"Management and prognosis of patients requiring prolonged mechanical ventilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     IDENTIFY AND CORRECT THE CAUSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Repeatedly unsuccessful attempts at weaning usually signify incomplete resolution of the illness that precipitated mechanical ventilation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the development of one or more new problems. Further weaning attempts should be withheld once a patient has failed multiple attempts at weaning until the potential causes of the ongoing ventilator dependency are identified and corrected.",
"   </p>",
"   <p>",
"    The potential causes of difficult weaning can be categorized according to whether they increase ventilatory demand, increase the resistive load, increase the elastic load, decrease neuromuscular capacity, or decrease ventilatory drive:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ventilatory demand is increased by hypoxemia (eg, atelectasis, morbid obesity, abdominal distension, lung disease, sepsis), elevated dead space (eg, hyperinflation, pulmonary embolism, dehydration), excess carbon dioxide production (eg, fever, infection, overfeeding), metabolic acidosis, or neuropsychiatric factors (eg, delirium, anxiety, pain).",
"     </li>",
"     <li>",
"      Resistive load increases with bronchoconstriction (eg, COPD, asthma), airway edema (eg, lower respiratory infection), secretions (eg, tracheobronchitis, pneumonia), or problems with the respiratory equipment (eg, endotracheal tube luminal narrowing due to inspissated secretions and debris).",
"     </li>",
"     <li>",
"      Elastic load rises whenever there is dynamic hyperinflation (eg, COPD, asthma, increased minute ventilation), alveolar filling (eg, pulmonary edema), atelectasis, pleural disease (eg, pleural effusion, pneumothorax), chest wall disease, or abdominal distension (eg, morbid obesity, ileus, ascites).",
"     </li>",
"     <li>",
"      Neuromuscular capacity is diminished by electrolyte abnormalities (eg, hypophosphatemia, hypomagnesemia, hypocalcemia, hypokalemia), medications (eg, steroids, neuromuscular blocking agents), malnutrition, hypothyroidism, systemic inflammation (eg, sepsis), neuropathy (eg, Guillain-Barre syndrome, critical illness polyneuropathy), and myopathy (eg, critical illness myopathy).",
"     </li>",
"     <li>",
"      Ventilatory drive is decreased by excess sedation, metabolic alkalosis (eg, nasogastric suctioning, volume depletion, diuretics and other causes of chloride depletion), central nervous system disease (eg, stroke, encephalopathy), central sleep apnea, or obesity hypoventilation syndrome.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Cardiac disease is a frequent contributor to difficult weaning:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Myocardial ischemia: Weaning increases both the work of breathing, which can induce myocardial ischemia in susceptible patients. The myocardial ischemia may further increase the work of breathing, creating a vicious cycle of weaning and myocardial ischemia exacerbating each other. A continuous multi-lead electrocardiogram (ECG) can be monitored during spontaneous breathing trials to detect weaning-related myocardial ischemia.",
"     </li>",
"     <li>",
"      Cardiac dysfunction: Negative intrathoracic pressure during spontaneous breathing increases left ventricular preload and afterload. This elevates the right atrial pressure (measured as the pulmonary artery occlusion pressure) and may induce pulmonary edema in patients with cardiac dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/4\">",
"       4",
"      </a>",
"      ]. Patients with cardiac dysfunction fail to appropriately increase their stroke volume and cardiac output during weaning [",
"      <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/5\">",
"       5",
"      </a>",
"      ], further contributing to the pulmonary edema by causing imbalance of cardiac supply and demand. The pulmonary edema may cause respiratory distress, leading to more negative intrathoracic pressure and further imbalance of cardiac supply and demand. This can worsen the pulmonary edema and establish a vicious cycle of weaning and pulmonary edema exacerbating each other.",
"      <br/>",
"      <br/>",
"      The possibility that weaning is limited by cardiac dysfunction is suggested by an elevated brain natriuretic peptide (BNP) or N-terminal pro-BNP prior to the weaning trial, an elevated N-terminal pro-BNP at the end of the trial, or a &gt;20 percent increase in BNP during the spontaneous breathing trial [",
"      <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/6-8\">",
"       6-8",
"      </a>",
"      ]. Alternatively, transthoracic or transesophageal echocardiography can be performed in intubated patients and used to identify left ventricular dysfunction.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All potential causes of difficult weaning should be treated because treatment may improve outcomes. As an example, in a series of 12 difficult-to-wean COPD patients with significant hypertension during failed spontaneous breathing trials, treatment with intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/24/11656?source=see_link\">",
"     nitroglycerin",
"    </a>",
"    was associated with successful weaning of 11 patients (92 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Once it is felt that the likely cause of ventilator dependency has been corrected, readiness testing can be performed to determine whether weaning is ready to resume. Readiness testing is described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/39/21112?source=see_link\">",
"     \"Weaning from mechanical ventilation: Readiness testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PSYCHOLOGICAL PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who are deemed ready to resume weaning should be psychologically prepared for the weaning process. Psychological issues (eg, anxiety) can be significant impediments to successful weaning. Interventions that may minimize stress include explaining the weaning plan to the patient, family, and other caretakers; arranging for a trusted caretaker to provide reassurance and explanation during weaning trials; biofeedback that displays the breathing pattern [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/10\">",
"     10",
"    </a>",
"    ]; ensuring adequate sleep; and environmental stimulation, such as television, radio, or books. Patients, family members, and caretakers should be warned in advance about the likelihood of setbacks and, when they occur, their cause should be identified and explained to the patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15336313\">",
"    <span class=\"h1\">",
"     WEANING STRATEGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Weaning may resume once the presumed impediments have been corrected and the patient, family, and caretakers have been prepared. Important initial considerations include the approach to the weaning trials, as well as the ventilator settings and other aspects of patient management to be used between weaning trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H580938\">",
"    <span class=\"h2\">",
"     During weaning trials",
"    </span>",
"    &nbsp;&mdash;&nbsp;Weaning trials in patients who are difficult-to-wean are virtually the same as those in patients who are weaning for the first time. This includes selection of a weaning mode, identifying weaning success or failure, and deciding whether or not to extubate the patient. These issues are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/5/14423?source=see_link\">",
"     \"Methods of weaning from mechanical ventilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H580946\">",
"    <span class=\"h2\">",
"     Between weaning trials",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mechanical ventilation between weaning trials is important and can have a profound impact on patients who are difficult-to-wean.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6001897\">",
"    <span class=\"h3\">",
"     Ventilator settings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Appropriate ventilator settings minimize the work of inflation performed by inspiratory muscles. This allows the muscles to rest and recover from the fatigue caused by the weaning trial. In contrast, inappropriate settings can create more work than is required for spontaneous breathing, leading to respiratory muscle fatigue and impairing successful weaning.",
"   </p>",
"   <p>",
"    There is no preferred mode of mechanical ventilation between weaning trials. Any mode may be used, as long as the settings (ie, tidal volume, respiratory rate,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pressure level) are such that the patient is comfortable and performing minimal work. Reasonable goals are settings that result in a respiratory rate between 12 and 20 breaths per minute, a tidal volume between 6 and 8",
"    <span class=\"nowrap\">",
"     mL/kg,",
"    </span>",
"    and a minute volume between 6 and 12",
"    <span class=\"nowrap\">",
"     L/min.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13336?source=see_link&amp;anchor=H15#H15\">",
"     \"Overview of mechanical ventilation\", section on 'Settings'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other ventilator settings that are often overlooked include the trigger method, trigger sensitivity, and inspiratory flow:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Trigger method: A ventilator-assisted breath can be triggered by a change in alveolar pressure (ie, pressure triggered) or flow (ie, flow triggered). Flow triggering is usually preferred because it is associated with less inspiratory effort in several modes of ventilation, even though the effect is usually small. This was demonstrated by studies that found that overall inspiratory effort was 30 to 40 percent lower with flow triggering than pressure triggering during intermittent mandatory ventilation (IMV) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/11,12\">",
"       11,12",
"      </a>",
"      ], 10 percent lower with flow triggering than pressure triggering during pressure support ventilation (PSV) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/13\">",
"       13",
"      </a>",
"      ], and unaltered by the triggering method during assist control ventilation (ACV) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/13\">",
"       13",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13336?source=see_link&amp;anchor=H16#H16\">",
"       \"Overview of mechanical ventilation\", section on 'Trigger'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Trigger sensitivity: The trigger setting should be sufficiently sensitive because, if it is not sensitive enough, the patient will need to work harder to trigger a ventilator-assisted breath [",
"      <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/14\">",
"       14",
"      </a>",
"      ]. During pressure triggering, the trigger sensitivity is usually set at -1 to -2 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O, which means that ventilator-assisted breaths will be triggered when the alveolar pressure decreases to 1 to 2 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O below atmospheric pressure. During flow triggering, the trigger sensitivity is usually set at 2",
"      <span class=\"nowrap\">",
"       L/min,",
"      </span>",
"      which means that ventilator-assisted breaths will be triggered once the patient's inspiratory effort generates a flow of 2",
"      <span class=\"nowrap\">",
"       L/min.",
"      </span>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13336?source=see_link&amp;anchor=H16#H16\">",
"       \"Overview of mechanical ventilation\", section on 'Trigger'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inspiratory flow: The inspiratory flow needs to be sufficient or the inspiratory work necessary to overcome pulmonary and ventilator impedance will be markedly increased (",
"      <a class=\"graphic graphic_figure graphicRef74214 \" href=\"UTD.htm?27/33/28191\">",
"       figure 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef56464 \" href=\"UTD.htm?29/50/30509\">",
"       figure 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]. A typical flow rate is 60",
"      <span class=\"nowrap\">",
"       L/min,",
"      </span>",
"      but some patients may benefit from increasing the inspiratory flow rate. An infrequent adverse consequence of increasing the flow rate is an immediate and persistent tachypnea [",
"      <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/16,17\">",
"       16,17",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13336?source=see_link&amp;anchor=H20#H20\">",
"       \"Overview of mechanical ventilation\", section on 'Flow rate'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Putting it all together, a reasonable initial approach is to use flow triggering in patients receiving IMV and in patients receiving PSV who have increased inspiratory effort during triggering. Either pressure or flow triggering is acceptable in other patients. A trigger sensitivity of -2 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O during pressure triggering or 2",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    during flow triggering is appropriate, with an initial inspiratory flow rate of 60",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    reasonable for most patients. The flow rate can be increased to as needed if a patient appears to be struggling.",
"   </p>",
"   <p>",
"    There are several additional considerations that may impact the ventilator settings between weaning trials:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic hypercapnia &ndash; Patients with chronic hypercapnia should be mechanically ventilated with a minute ventilation that maintains the patient's usual arterial carbon dioxide tension (PaCO",
"      <sub>",
"       2",
"      </sub>",
"      ). A common mistake is to ventilate a patient who has chronic hypercapnia with a minute ventilation that normalizes the PaCO",
"      <sub>",
"       2",
"      </sub>",
"      . This will cause the pH to rise and the kidneys will respond by excreting bicarbonate over the next three to five days until the pH normalizes. When the patient resumes spontaneous ventilation and hypercapnia develops, an acute respiratory acidosis will result because there will be insufficient bicarbonate for buffering.",
"     </li>",
"     <li>",
"      Auto-PEEP &ndash; Auto-PEEP is the increased alveolar pressure at the end of expiration due to progressive air trapping caused by incomplete expiration prior to the initiation of the next breath. It occasionally develops during mechanical ventilation and has undesirable effects that cause respiratory muscle fatigue and impair weaning. First, auto-PEEP increases the work of breathing [",
"      <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/18-20\">",
"       18-20",
"      </a>",
"      ]. Second, it impedes the triggering of ventilator-assisted breaths because it increases the amount of respiratory effort that is required to lower the alveolar pressure to the trigger sensitivity (",
"      <a class=\"graphic graphic_figure graphicRef76380 \" href=\"UTD.htm?35/46/36578\">",
"       figure 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/21-24\">",
"       21-24",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      As an example, consider a patient whose extrinsic PEEP is set to 5 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O and trigger sensitivity is set to -2 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O. When there is no auto-PEEP, the patient must lower the alveolar pressure only 2 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O to reach the trigger sensitivity, from 5 to 3 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O. In contrast, when the auto-PEEP is 10 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O, the patient must lower the alveolar pressure 7 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O to reach the trigger sensitivity, from 10 to 3 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O.",
"      <br/>",
"      <br/>",
"      Auto-PEEP may be reduced by increasing the inspiratory flow rate or reducing the respiratory rate (both interventions increase the expiratory time), or by reducing the tidal volume. Small studies suggest that the effects of auto-PEEP can be countered by applied PEEP (ie, extrinsic PEEP) in patients whose auto-PEEP is due to an expiratory flow limitation (",
"      <a class=\"graphic graphic_figure graphicRef82364 \" href=\"UTD.htm?13/2/13359\">",
"       figure 4",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/25,26\">",
"       25,26",
"      </a>",
"      ]. The treatment of applied PEEP is discussed in greater detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/60/30663?source=see_link&amp;anchor=H20#H20\">",
"       \"Positive end-expiratory pressure (PEEP)\", section on 'Auto-PEEP'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6001962\">",
"    <span class=\"h3\">",
"     Respiratory muscle training",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important that a weaning trial be terminated if the patient is failing the trial, since respiratory muscle fatigue may develop. Rest is the only treatment for such fatigue and recovery can take several days, delaying further weaning.",
"   </p>",
"   <p>",
"    Inspiratory muscles can be trained, improving strength and endurance so that fatigue occurs less easily. This is done by adding a resistance device to the inspiratory limb of the ventilator circuit. The effects of training were illustrated by a trial that randomly assigned 69 patients undergoing mechanical ventilation to receive a threshold inspiratory device (set at the highest pressure tolerated and progressed daily) or a sham device [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/27\">",
"     27",
"    </a>",
"    ]. The devices were added to the inspiratory limbs of the ventilator circuit and four sets of six to ten training breaths were performed five days per week. Patients who received the threshold inspiratory device had an increase in their maximal inspiratory pressure (from -44 to -54 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O), while patients who received the sham device did not. Patients who received the threshold inspiratory device also required fewer days of mechanical ventilation, although the difference was not statistically significant, suggesting that larger trials with more events are needed to confirm or exclude the effect.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6001713\">",
"    <span class=\"h1\">",
"     RESPIRATORY CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient&lsquo;s respiratory status should be optimized both during and between weaning trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6001638\">",
"    <span class=\"h2\">",
"     Ventilator circuit",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ventilator circuit-related problems can increase respiratory work and, therefore, the circuit should be closely monitored and problems quickly identified and corrected. Potential problems include equipment dead space, circuit compliance, gas compression volume, exhalation valve function, and increased resistance caused by the endotracheal tube, inspiratory circuit, or expiratory circuit [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. The pressure and flow tracings on the ventilator screen can provide clues to ventilator-related problems:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased peak airway pressure with little or no change in the plateau pressure indicates increased resistance in the endotracheal tube or respiratory circuit.",
"     </li>",
"     <li>",
"      Increased baseline airway pressure may signal malfunction of the exhalation valve (or inadvertent PEEP).",
"     </li>",
"     <li>",
"      Continued neural inspiration (contraction of inspiratory muscles) after the ventilator has cycled to the expiratory phase (ie, premature opening of the exhalation valve) can appear as minimal or no inspiratory flow, despite patient inspiratory effort. This may lead to a transient prominent decrease from peak expiratory flow, followed by increase and then a slow decrease again as neural expiration ends [",
"      <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/30\">",
"       30",
"      </a>",
"      ].&nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Airway management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Airway management encompasses secretion management, bronchodilation, and tracheostomy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Airway secretions should be suctioned before every weaning trial.",
"     </li>",
"     <li>",
"      Bronchodilators may facilitate weaning in patients with airway obstruction by reducing airway resistance and the work of breathing [",
"      <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/31,32\">",
"       31,32",
"      </a>",
"      ]. Bronchodilators can be delivered effectively and conveniently to mechanically ventilated patients by inserting a metered-dose inhaler into the inspiratory limb of the ventilator circuit. We use short-acting aerosolized beta-adrenergic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      anticholinergic agents prior to a weaning trial in most patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A tracheostomy can be advantageous in the difficult-to-wean patient because it increases patient comfort (ie, decreases the work of breathing, decreases intrinsic PEEP, and improves patient-ventilator synchrony) and oral hygiene [",
"      <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]. It also facilitates verbal communication, which is beneficial since the inability of patients to speak while intubated is a major cause of fear and anxiety [",
"      <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/35\">",
"       35",
"      </a>",
"      ]. The time of tracheostomy is discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/42/11945?source=see_link\">",
"       \"Overview of tracheostomy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Posture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should be placed in the posture that they prefer during a weaning trial, which may vary according to the pathophysiology [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/36\">",
"     36",
"    </a>",
"    ]. Patients with diaphragmatic paralysis generally prefer and perform better in an upright position because their vital capacity decreases when they are horizontal. In contrast, patients with intercostal muscle weakness (eg, due to a low cervical cord lesion) may prefer being supine because their lung volumes tend to increase when they move from an upright to a supine position. In patients with chronic obstructive pulmonary disease, the optimal posture varies. Some patients have less dyspnea when they are lying supine, whereas others prefer to lean forward.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6002069\">",
"    <span class=\"h1\">",
"     PHYSICAL THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early mobilization of mechanically ventilated patients appears to improve clinical outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/37-40\">",
"     37-40",
"    </a>",
"    ], including weaning [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/37\">",
"     37",
"    </a>",
"    ]. This was illustrated by a trial in which 104 patients mechanically ventilated for &lt;72 hours were randomly assigned to receive either no mobilization or progressive physical therapy focused on mobilization [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/37\">",
"     37",
"    </a>",
"    ]. Mobilization activities include sitting at the edge of the bed, engaging in simulated activities of daily living, transfer training, and ambulation. Patients who received progressive physical therapy had more ventilator-free days (24 versus 21 days), were more likely to go directly home after hospitalization, had fewer days with delirium, and had better walking distances while in the hospital than patients who did not receive mobilization.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     NUTRITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Protein catabolism induced by critical illness leads to decreased respiratory muscle mass, strength, and endurance, which may lead to difficulty weaning from mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/41\">",
"     41",
"    </a>",
"    ]. Nutrition support may minimize these effects and improve both weaning success and other clinical outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/42-45\">",
"     42-45",
"    </a>",
"    ], as long as the amount of nutrition support is adequate without being excessive. Inadequate nutrition is associated with little to no improvement in clinical outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/42-45\">",
"     42-45",
"    </a>",
"    ], probably because it fails to sufficiently mitigate the loss of respiratory muscle mass, strength, and endurance. Conversely, overfeeding with excessive carbohydrates can impair ventilator withdrawal [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/42\">",
"     42",
"    </a>",
"    ], presumably by leading to excess carbon dioxide production and an increased ventilatory load on the respiratory muscles. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13831?source=see_link\">",
"     \"Nutrition support in critically ill patients: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6002077\">",
"    <span class=\"h1\">",
"     TRANSFER TO LONG-TERM ACUTE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients remain difficult-to-wean even though their acute illness has resolved and they are otherwise stable. The care of such patients may be transferred to specialized weaning units. Such weaning units are often free-standing facilities known as long-term acute care (LTAC) hospitals or satellite units of an LTAC hospital. The latter are frequently located within an acute care hospital.",
"   </p>",
"   <p>",
"    LTAC facilities provide a site where prolonged mechanical ventilation and weaning are the primary focus. They foster involvement of the patient in decision-making and provide an environment that integrates the family and other caregivers into a supportive health care team. This team includes intensivists, internists, nurses, and respiratory therapists who identify weaning goals and coordinate the weaning process. In addition, there is daily patient-centered rehabilitation that includes physical exercise for regaining muscle strength and practice performing activities of daily living. Skilled therapists are also available to focus on issues such as speech and communication, nutrition support, physical and recreational activities, and counseling.",
"   </p>",
"   <p>",
"    Several factors are considered when determining whether a patient is appropriate for transfer to a specialized weaning center. First, the acute illness should be resolved. Second, the patient should not be dyspneic or hypoxemic during mechanical ventilation. Third, patients should have a stable airway and route to receive nutrition, which usually consists of a tracheostomy and enteral feeding tube [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The number of patients in specialized weaning units increased three-times between 1997 and 2006, reflecting the trend to manage such patients outside of the intensive care unit [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/47\">",
"     47",
"    </a>",
"    ]. &nbsp;Studies from specialized weaning centers indicate that nearly half of patients admitted to specialized weaning centers can be successfully weaned from full-time mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9176/abstract/48\">",
"     48",
"    </a>",
"    ]. Strategies for weaning patients who are in an LTAC facility for prolonged mechanical ventilation and their outcomes are described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37673?source=see_link\">",
"     \"Management and prognosis of patients requiring prolonged mechanical ventilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients are considered to have undergone simple weaning if they pass their first spontaneous breathing trial (SBT). They are considered difficult-to-wean if they fail their first SBT and then require up to three SBTs or seven days to pass a SBT. Finally, patients are considered to have undergone prolonged weaning if they fail at least three SBTs or require more than seven days to pass a SBT. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Repeated unsuccessful attempts at weaning usually signify incomplete resolution of the illness that precipitated mechanical ventilation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the development of one or more new problems. Further weaning attempts should be withheld once a patient has failed multiple attempts at weaning until the potential causes of the ongoing ventilator dependency are identified and corrected. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Identify and correct the cause'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Once it is felt that the likely cause of ventilator dependency has been corrected, readiness testing can be performed to determine whether weaning is ready to resume. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/39/21112?source=see_link\">",
"       \"Weaning from mechanical ventilation: Readiness testing\"",
"      </a>",
"      .).",
"     </li>",
"     <li>",
"      Patients who are deemed ready to resume weaning should be psychologically prepared for the weaning process because psychological issues (eg, anxiety) can be significant impediments to successful weaning. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Psychological preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Weaning may resume once the presumed impediments have been corrected and the patient, family, and caretakers have been prepared. Important initial considerations include the approach to the weaning trials, as well as the ventilator settings and other aspects of patient management to be used between weaning trials:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Weaning trials in patients who are difficult-to-wean are virtually the same as those in patients who are weaning for the first time. This includes selection of a weaning mode, identifying weaning success or failure, and deciding whether or not to extubate the patient. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/5/14423?source=see_link\">",
"       \"Methods of weaning from mechanical ventilation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      It is important that a weaning trial be terminated if the patient is failing the trial, since respiratory muscle fatigue may develop. Rest is the only treatment for such fatigue and recovery can take several days, delaying further weaning. (See",
"      <a class=\"local\" href=\"#H6001962\">",
"       'Respiratory muscle training'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mechanical ventilation between weaning trials can have a profound effect. Appropriate ventilator settings allow the muscles to rest and recover from fatigue caused by the weaning trial. (See",
"      <a class=\"local\" href=\"#H6001897\">",
"       'Ventilator settings'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient&lsquo;s respiratory status should be optimized both during and between weaning trials. This includes suctioning airway secretions before every weaning trial and as-needed, administering a short-acting bronchodilator prior to every weaning trial and as-needed, placing the patient the posture that they prefer, and quickly correcting ventilator circuit problems. (See",
"      <a class=\"local\" href=\"#H6001713\">",
"       'Respiratory care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Early mobilization and nutrition support may improve weaning success. (See",
"      <a class=\"local\" href=\"#H6002069\">",
"       'Physical therapy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Nutrition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some patients remain difficult-to-wean even though their acute illness has resolved and they are otherwise stable. The care of such patients may be transferred to specialized weaning units. (See",
"      <a class=\"local\" href=\"#H6002077\">",
"       'Transfer to long-term acute care'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8009009\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Amal Jubran and Dr. Martin Tobin, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/1\">",
"      Boles JM, Bion J, Connors A, et al. Weaning from mechanical ventilation. Eur Respir J 2007; 29:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/2\">",
"      Funk GC, Anders S, Breyer MK, et al. Incidence and outcome of weaning from mechanical ventilation according to new categories. Eur Respir J 2010; 35:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/3\">",
"      Pe&ntilde;uelas O, Frutos-Vivar F, Fern&aacute;ndez C, et al. Characteristics and outcomes of ventilated patients according to time to liberation from mechanical ventilation. Am J Respir Crit Care Med 2011; 184:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/4\">",
"      Lemaire F, Teboul JL, Cinotti L, et al. Acute left ventricular dysfunction during unsuccessful weaning from mechanical ventilation. Anesthesiology 1988; 69:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/5\">",
"      Jubran A, Mathru M, Dries D, Tobin MJ. Continuous recordings of mixed venous oxygen saturation during weaning from mechanical ventilation and the ramifications thereof. Am J Respir Crit Care Med 1998; 158:1763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/6\">",
"      Mekontso-Dessap A, de Prost N, Girou E, et al. B-type natriuretic peptide and weaning from mechanical ventilation. Intensive Care Med 2006; 32:1529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/7\">",
"      Grasso S, Leone A, De Michele M, et al. Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease. Crit Care Med 2007; 35:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/8\">",
"      Chien JY, Lin MS, Huang YC, et al. Changes in B-type natriuretic peptide improve weaning outcome predicted by spontaneous breathing trial. Crit Care Med 2008; 36:1421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/9\">",
"      Routsi C, Stanopoulos I, Zakynthinos E, et al. Nitroglycerin can facilitate weaning of difficult-to-wean chronic obstructive pulmonary disease patients: a prospective interventional non-randomized study. Crit Care 2010; 14:R204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/10\">",
"      Holliday JE, Hyers TM. The reduction of weaning time from mechanical ventilation using tidal volume and relaxation biofeedback. Am Rev Respir Dis 1990; 141:1214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/11\">",
"      Sassoon CS, Del Rosario N, Fei R, et al. Influence of pressure- and flow-triggered synchronous intermittent mandatory ventilation on inspiratory muscle work. Crit Care Med 1994; 22:1933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/12\">",
"      Giuliani R, Mascia L, Recchia F, et al. Patient-ventilator interaction during synchronized intermittent mandatory ventilation. Effects of flow triggering. Am J Respir Crit Care Med 1995; 151:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/13\">",
"      Aslanian P, El Atrous S, Isabey D, et al. Effects of flow triggering on breathing effort during partial ventilatory support. Am J Respir Crit Care Med 1998; 157:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/14\">",
"      Ward ME, Corbeil C, Gibbons W, et al. Optimization of respiratory muscle relaxation during mechanical ventilation. Anesthesiology 1988; 69:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/15\">",
"      Marini JJ, Rodriguez RM, Lamb V. The inspiratory workload of patient-initiated mechanical ventilation. Am Rev Respir Dis 1986; 134:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/16\">",
"      Puddy A, Younes M. Effect of inspiratory flow rate on respiratory output in normal subjects. Am Rev Respir Dis 1992; 146:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/17\">",
"      Laghi F, Segal J, Choe WK, Tobin MJ. Effect of imposed inflation time on respiratory frequency and hyperinflation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:1365.",
"     </a>",
"    </li>",
"    <li>",
"     Tobin MJ, Alex CA, Fahey PJ. Fighting the ventilator. In: Principles and Practice of Mechanical Ventilation, Tobin MJ (Ed), McGraw Hill, Inc., New York 2006. p.1121.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/19\">",
"      Coussa ML, Gu&eacute;rin C, Eissa NT, et al. Partitioning of work of breathing in mechanically ventilated COPD patients. J Appl Physiol 1993; 75:1711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/20\">",
"      Jubran A, Van de Graaff WB, Tobin MJ. Variability of patient-ventilator interaction with pressure support ventilation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/21\">",
"      Tobin MJ, Jubran A, Laghi F. Patient-ventilator interaction. Am J Respir Crit Care Med 2001; 163:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/22\">",
"      Tobin MJ. Advances in mechanical ventilation. N Engl J Med 2001; 344:1986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/23\">",
"      Rossi A, Gottfried SB, Zocchi L, et al. Measurement of static compliance of the total respiratory system in patients with acute respiratory failure during mechanical ventilation. The effect of intrinsic positive end-expiratory pressure. Am Rev Respir Dis 1985; 131:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/24\">",
"      Leung P, Jubran A, Tobin MJ. Comparison of assisted ventilator modes on triggering, patient effort, and dyspnea. Am J Respir Crit Care Med 1997; 155:1940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/25\">",
"      Ranieri VM, Giuliani R, Cinnella G, et al. Physiologic effects of positive end-expiratory pressure in patients with chronic obstructive pulmonary disease during acute ventilatory failure and controlled mechanical ventilation. Am Rev Respir Dis 1993; 147:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/26\">",
"      Smith TC, Marini JJ. Impact of PEEP on lung mechanics and work of breathing in severe airflow obstruction. J Appl Physiol 1988; 65:1488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/27\">",
"      Martin AD, Smith BK, Davenport PD, et al. Inspiratory muscle strength training improves weaning outcome in failure to wean patients: a randomized trial. Crit Care 2011; 15:R84.",
"     </a>",
"    </li>",
"    <li>",
"     Jubran A, Tobin MJ. Monitoring during mechanical ventilation. In: Principles and Practice of Mechanical Ventilation, Tobin MJ (Ed), McGraw Hill, Inc., New York 2006. p.1051.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/29\">",
"      Girault C, Breton L, Richard JC, et al. Mechanical effects of airway humidification devices in difficult to wean patients. Crit Care Med 2003; 31:1306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/30\">",
"      Georgopoulos D, Prinianakis G, Kondili E. Bedside waveforms interpretation as a tool to identify patient-ventilator asynchronies. Intensive Care Med 2006; 32:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/31\">",
"      Mancebo J, Amaro P, Lorino H, et al. Effects of albuterol inhalation on the work of breathing during weaning from mechanical ventilation. Am Rev Respir Dis 1991; 144:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/32\">",
"      Dhand R, Jubran A, Tobin MJ. Bronchodilator delivery by metered-dose inhaler in ventilator-supported patients. Am J Respir Crit Care Med 1995; 151:1827.",
"     </a>",
"    </li>",
"    <li>",
"     Heffner JE, Martin-Harris B. Care of the mechanically ventilated patient with a tracheotomy. In: Principles and Practice of Mechanical Ventilation, Tobin MJ (Ed), McGraw Hill, Inc., New York 2006. p.847.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/34\">",
"      Diehl JL, El Atrous S, Touchard D, et al. Changes in the work of breathing induced by tracheotomy in ventilator-dependent patients. Am J Respir Crit Care Med 1999; 159:383.",
"     </a>",
"    </li>",
"    <li>",
"     Martin U, Criner GJ. Psychological problems in the ventilated patient. In: Principles and Practice of Mechanical Ventilation, Tobin MJ (Ed), McGraw Hill, Inc., New York 2006. p.1137.",
"    </li>",
"    <li>",
"     Tobin MJ, Jubran A. Weaning from mechanical ventilation. In: Principles and Practice of Mechanical Ventilation, Tobin MJ (Ed), McGraw Hill, Inc., New York 2006. p.1185.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/37\">",
"      Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009; 373:1874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/38\">",
"      Morris PE, Goad A, Thompson C, et al. Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med 2008; 36:2238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/39\">",
"      Burtin C, Clerckx B, Robbeets C, et al. Early exercise in critically ill patients enhances short-term functional recovery. Crit Care Med 2009; 37:2499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/40\">",
"      Needham DM, Korupolu R, Zanni JM, et al. Early physical medicine and rehabilitation for patients with acute respiratory failure: a quality improvement project. Arch Phys Med Rehabil 2010; 91:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/41\">",
"      Laghi F, Tobin MJ. Disorders of the respiratory muscles. Am J Respir Crit Care Med 2003; 168:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/42\">",
"      Krishnan JA, Parce PB, Martinez A, et al. Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes. Chest 2003; 124:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/43\">",
"      Stapleton RD, Jones N, Heyland DK. Feeding critically ill patients: what is the optimal amount of energy? Crit Care Med 2007; 35:S535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/44\">",
"      Alberda C, Gramlich L, Jones N, et al. The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med 2009; 35:1728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/45\">",
"      Faisy C, Lerolle N, Dachraoui F, et al. Impact of energy deficit calculated by a predictive method on outcome in medical patients requiring prolonged acute mechanical ventilation. Br J Nutr 2009; 101:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/46\">",
"      Scheinhorn DJ, Hassenpflug MS, Votto JJ, et al. Ventilator-dependent survivors of catastrophic illness transferred to 23 long-term care hospitals for weaning from prolonged mechanical ventilation. Chest 2007; 131:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/47\">",
"      Kahn JM, Benson NM, Appleby D, et al. Long-term acute care hospital utilization after critical illness. JAMA 2010; 303:2253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9176/abstract/48\">",
"      O'Connor HH, Kirby KJ, Terrin N, et al. Decannulation following tracheostomy for prolonged mechanical ventilation. J Intensive Care Med 2009; 24:187.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1646 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-FD0A04FE88-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_61_9176=[""].join("\n");
var outline_f8_61_9176=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      IDENTIFY AND CORRECT THE CAUSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PSYCHOLOGICAL PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15336313\">",
"      WEANING STRATEGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H580938\">",
"      During weaning trials",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H580946\">",
"      Between weaning trials",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6001897\">",
"      - Ventilator settings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6001962\">",
"      - Respiratory muscle training",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6001713\">",
"      RESPIRATORY CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6001638\">",
"      Ventilator circuit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Airway management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Posture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6002069\">",
"      PHYSICAL THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      NUTRITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6002077\">",
"      TRANSFER TO LONG-TERM ACUTE CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8009009\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/1646\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1646|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/33/28191\" title=\"figure 1\">",
"      Flow rate and work",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/50/30509\" title=\"figure 2\">",
"      Inspiratory flow rate vs work",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/46/36578\" title=\"figure 3\">",
"      Inspiratory effort triggering",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/2/13359\" title=\"figure 4\">",
"      Applied PEEP and work",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37673?source=related_link\">",
"      Management and prognosis of patients requiring prolonged mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/5/14423?source=related_link\">",
"      Methods of weaning from mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13831?source=related_link\">",
"      Nutrition support in critically ill patients: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13336?source=related_link\">",
"      Overview of mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/42/11945?source=related_link\">",
"      Overview of tracheostomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/60/30663?source=related_link\">",
"      Positive end-expiratory pressure (PEEP)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/39/21112?source=related_link\">",
"      Weaning from mechanical ventilation: Readiness testing",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_61_9177="Dividing left round ligament";
var content_f8_61_9177=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F65238%7EOBGYN%2F68003%7EOBGYN%2F58377&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F65238%7EOBGYN%2F68003%7EOBGYN%2F58377&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dividing the left round ligament lateral to the umbilical ligament",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ken Hatch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left round ligament opened lateral to the umbilical ligament",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 276px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ken Hatch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anatomy of left pelvic vessels",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ken Hatch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_61_9177=[""].join("\n");
var outline_f8_61_9177=null;
var title_f8_61_9178="Severe malnutrition in children in developing countries: Treatment";
var content_f8_61_9178=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Severe malnutrition in children in developing countries: Treatment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/61/9178/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/61/9178/contributors\">",
"     William J Klish, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/61/9178/contributors\">",
"     Buford L Nichols, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/61/9178/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/61/9178/contributors\">",
"     Kathleen J Motil, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/61/9178/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/61/9178/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/61/9178/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe malnutrition is primarily a problem in developing countries. Severely malnourished children typically are brought to medical attention when a health crisis, such as an infection, precipitates the transition between marasmus (a state of nutritional adaptation) and kwashiorkor, in which adaptation is no longer adequate. In some cases malnutrition is precipitated by political disruptions like war or natural disasters like drought, which interfere with the food supply. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32248?source=see_link&amp;anchor=H2#H2\">",
"     \"Malnutrition in developing countries: Clinical assessment\", section on 'Protein-energy malnutrition'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An intensive and comprehensive approach is required to reduce the mortality rate associated with this condition and improve outcome. The initial nutritional and medical management, rehabilitation, and follow-up of children from developing countries with severe malnutrition are reviewed here. Causes and clinical manifestations associated with this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32248?source=see_link\">",
"     \"Malnutrition in developing countries: Clinical assessment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/4/38983?source=see_link\">",
"     \"Micronutrient deficiencies associated with malnutrition in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The treatment of malnourished children from developed countries is discussed elsewhere. Although the principles of treatment of malnourished children from developed countries are similar to those from developing countries, the specific details may vary based on local customs and resources. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/16/30985?source=see_link\">",
"     \"Management of failure to thrive (undernutrition) in children younger than two years\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The approach to treating children with severe malnutrition as inpatients in hospitals or feeding centers, as promoted by the World Health Organization (WHO) protocol, is described below. A different approach to management of malnutrition, known as community-based therapeutic care (CTC) is also discussed briefly. This approach appears to produce equal recovery and case fatality rates, and to increase population coverage, and has been successfully implemented by relief organizations. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Community-based therapeutic care'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The World Health Organization (WHO) developed criteria for the classification of severe malnutrition in children [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/1\">",
"     1",
"    </a>",
"    ]. These criteria are based upon the degree of wasting or stunting and the presence of edema (",
"    <a class=\"graphic graphic_table graphicRef60869 \" href=\"UTD.htm?12/59/13244\">",
"     table 1",
"    </a>",
"    ). The child's weight for his or her height and the height for his or her age are expressed as Z-scores (also known as the standard deviation [SD] score), calculated as the observed value minus the median value of the reference population divided by the standard deviation of the reference population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Charts",
"    </span>",
"    &nbsp;&mdash;&nbsp;The degree of malnutrition can be determined by plotting the height and weight on Z-score charts. Charts based on recumbent length are used for children up to two years of age (",
"    <a class=\"graphic graphic_figure graphicRef64985 graphicRef76745 graphicRef77428 graphicRef56424 \" href=\"UTD.htm?32/40/33418\">",
"     figure 1A-D",
"    </a>",
"    ) and charts based on standing height are used for those between two and five years (",
"    <a class=\"graphic graphic_figure graphicRef53829 graphicRef64531 graphicRef56071 graphicRef67900 \" href=\"UTD.htm?31/40/32394\">",
"     figure 2A-D",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/1\">",
"     1",
"    </a>",
"    ]. Wasting and stunting are defined by the following (these diagnoses are not mutually exclusive):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Wasting (indicates acute malnutrition):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Moderate wasting &mdash;",
"      <span class=\"nowrap\">",
"       weight/height",
"      </span>",
"      z-score &lt;-2 to -3",
"     </li>",
"     <li>",
"      Severe wasting &mdash;",
"      <span class=\"nowrap\">",
"       weight/height",
"      </span>",
"      z-score &lt;-3",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stunting (indicates chronic malnutrition):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Moderate stunting &mdash; height or length z-score &lt;-2 to -3",
"     </li>",
"     <li>",
"      Severe stunting &mdash; height or length z-score &lt;-3",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Malnutrition:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Moderate malnutrition &mdash; moderate wasting or stunting",
"     </li>",
"     <li>",
"      Severe malnutrition &mdash; severe wasting, severe stunting, OR edematous malnutrition",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These reference values were developed by the WHO, and derived from several populations of healthy breast-fed infants [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/2\">",
"     2",
"    </a>",
"    ]. As compared with the standards prepared by the Centers for Disease control, the WHO standards result in lower prevalence estimates of undernutrition, except during the first six months of life, and higher rates of obesity [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children with symmetrical edema involving at least the feet are considered to have severe malnutrition. Children with severe wasting or symmetrical edema (also known as edematous malnutrition) should be admitted to the hospital for treatment. It should be noted that children with",
"    <span class=\"nowrap\">",
"     HIV/AIDS",
"    </span>",
"    in the developing world frequently present with a combination of wasting and stunting, sometimes making the interpretation of the WHO criteria for malnutrition difficult.",
"   </p>",
"   <p>",
"    An alternate approach to defining wasting is to use mid-arm muscle circumference (MAMC), with MAMC &lt;115 mm defining severe wasting [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32248?source=see_link&amp;anchor=H10091096#H10091096\">",
"     \"Malnutrition in developing countries: Clinical assessment\", section on 'Mid upper arm circumference'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Calculators",
"    </span>",
"    &nbsp;&mdash;&nbsp;Z-scores and percentiles may be calculated using the following calculators, which are based on the WHO child growth standards.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infants zero to two years:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; Boys (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?35/40/36485?source=see_link\">",
"     calculator 1",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; Girls (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?36/1/36885?source=see_link\">",
"     calculator 2",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children two to five years:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; Boys (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?29/32/30213?source=see_link\">",
"     calculator 3",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; Girls (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?29/48/30469?source=see_link\">",
"     calculator 4",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     WHO MANAGEMENT GUIDELINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The protocol for management of severely malnourished children developed by WHO consists of three phases: initial stabilization, rehabilitation, and follow-up. The approach is based upon the altered nutritional physiology of the edematous malnourished child (",
"    <a class=\"graphic graphic_table graphicRef77579 graphicRef54640 graphicRef62304 \" href=\"UTD.htm?23/19/23870\">",
"     table 2A-C",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/1\">",
"     1",
"    </a>",
"    ], and has been validated in the field [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. The ten steps in the process are outlined in the figure (",
"    <a class=\"graphic graphic_figure graphicRef76855 \" href=\"UTD.htm?1/6/1134\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The initial phase is a critical time with an emphasis on treatment of hypoglycemia, hypothermia, and dehydration, and the detection and treatment of infection. Feedings are begun in this period and advanced after the first week as the rehabilitation phase begins. Deficiencies of electrolytes and vitamins are treated throughout initial and rehabilitation phases, except that iron supplementation is delayed until the beginning of rehabilitation.",
"     </li>",
"     <li>",
"      The rehabilitation phase lasts approximately two to six weeks. During this phase, the mother is trained to continue care at home, and any social problems are addressed. Emotional stimulation and sensory development of the child extends throughout the initial and rehabilitation phases.",
"     </li>",
"     <li>",
"      In the follow-up phase, the physical, mental, and emotional development of the child are monitored after discharge.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     INITIAL PHASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial phase is a critical time that emphasizes treatment of disorders that may be life-threatening, including hypoglycemia, hypothermia, infection, and dehydration. Prolonged fasting that may be required for diagnostic procedures should be delayed until the end of this phase. The composition of the initial diet and the electrolyte solution are outlined below [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hypoglycemia and hypothermia occur with fasting of four to six hours duration or can be precipitated by a serious systemic infection. These conditions may be associated with apnea. These disorders usually respond to early and frequent feedings and temperature control. Blood glucose should be monitored if hypothermia or apnea occurs [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Treatment priorities are temperature control (warming), antibiotics for infection, and rehydration. Feedings are begun in this period. They are advanced as the child&rsquo;s appetite returns during or after the first week, as the rehabilitation phase begins.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Warming",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the rectal temperature is &lt;35.5 degrees C, the child should be warmed. This can be accomplished using a warm blanket or with an incandescent lamp directed on, but not touching, the child's body. If these options are not available, the child can be warmed by close contact with the mother&rsquo;s body. Hypothermia may be a sign of sepsis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Broad-spectrum antibiotics should be started because many children with severe malnutrition have systemic infections [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Blood cultures should be obtained, but because these children are severely ill, treatment should be initiated while awaiting results.",
"   </p>",
"   <p>",
"    The WHO recommends the following choices of antibiotics for the initial treatment of malnourished children, based on likely pathogens and antibiotic availability in developing countries [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/1,12\">",
"     1,12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If there are no apparent complications:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Sulfamethoxazole",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/8/5255?source=see_link\">",
"       trimethoprim",
"      </a>",
"      suspension, 5 mL orally twice daily for five days if weight &gt;4 kg; or 2.5 mL twice daily for five days if weight &lt;4 kg (5 mL is equivalent to 40 mg TMP and 200 mg SMX).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If there are symptoms suggesting complications (hypoglycemia, hypothermia, lethargy):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       Ampicillin",
"      </a>",
"      (50",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      <span class=\"nowrap\">",
"       IM/IV",
"      </span>",
"      every six hours) for two days, then",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/49/34583?source=see_link\">",
"       amoxicillin",
"      </a>",
"      (15",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      orally three times daily) for five days.",
"     </li>",
"     <li>",
"      AND",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"       gentamicin",
"      </a>",
"      (7.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      <span class=\"nowrap\">",
"       IM/IV)",
"      </span>",
"      once daily for seven days.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the child fails to improve within 48 hours:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Add",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?4/35/4664?source=see_link\">",
"       chloramphenicol",
"      </a>",
"      (25",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      <span class=\"nowrap\">",
"       IM/IV",
"      </span>",
"      every eight hours) for five days.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other antibiotic regimens may be appropriate if specific pathogens are suspected",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    if an appropriately broad antimicrobial spectrum can be covered with alternate available antibiotics.",
"   </p>",
"   <p>",
"    Septic shock should be differentiated from dehydration if possible, although these conditions may coexist in the severely malnourished child (",
"    <a class=\"graphic graphic_table graphicRef63299 \" href=\"UTD.htm?33/41/34460\">",
"     table 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/1\">",
"     1",
"    </a>",
"    ]. Helpful distinguishing clinical features include weak or absent pulses, which are likely to occur in septic shock rather than dehydration (although cold hands and feet may occur in either condition) and thirst, and sunken eyes and fontanel, which are characteristic of dehydration and do not occur in sepsis. However, typical signs of dehydration (eg, lack of moisture of the mouth and poor skin elasticity) are not reliable in severely malnourished children. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32248?source=see_link\">",
"     \"Malnutrition in developing countries: Clinical assessment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     REHYDRATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The malnourished child may have acute and persistent diarrhea and has reduced homeostatic capacity to cope with water and potassium deficits. As noted above, dehydration must be differentiated from septic shock, although the two conditions sometimes coexist (",
"    <a class=\"graphic graphic_table graphicRef63299 \" href=\"UTD.htm?33/41/34460\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Dehydration in the malnourished child should be treated with oral rehydration whenever possible [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/1,13\">",
"     1,13",
"    </a>",
"    ]. In the setting of severe malnutrition, intravenous hydration may lead to overhydration and heart failure. As a result, IV infusion should be used only in the setting of severe hypovolemia or shock. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/17/17688?source=see_link\">",
"     \"Treatment of hypovolemia (dehydration) in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     ReSoMal",
"    </span>",
"    &nbsp;&mdash;&nbsp;ReSoMal is an oral rehydration solution developed for use in severely malnourished children. It consists of the standard WHO rehydration oral solution (ORS) that has been modified by decreasing sodium and increasing potassium concentrations (",
"    <a class=\"graphic graphic_table graphicRef53739 \" href=\"UTD.htm?20/0/20491\">",
"     table 4",
"    </a>",
"    ). This solution is used to correct the hypernatremia and potassium deficiency that occur in severe malnutrition. ReSoMal contains glucose (125",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    sodium (45",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    potassium (40",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    magnesium (3",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    zinc (0.3",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    and copper (0.045",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    ReSoMal is available commercially.",
"   </p>",
"   <p>",
"    This solution also can be made as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dilute one packet of the standard WHO-recommended ORS into two liters of water (instead of one liter of water used for the standard ORS dilution).",
"     </li>",
"     <li>",
"      Add 50 g of sucrose (25",
"      <span class=\"nowrap\">",
"       g/L);",
"      </span>",
"      50 g of sucrose is approximately 4 tablespoons.",
"     </li>",
"     <li>",
"      Add 40 mL (20",
"      <span class=\"nowrap\">",
"       ml/L)",
"      </span>",
"      of mineral mix solution (",
"      <a class=\"graphic graphic_table graphicRef61359 \" href=\"UTD.htm?25/38/26219\">",
"       table 5",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Rehydration methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the child is able to drink, the solution is given by mouth. The required amount can be given as sips or by spoon every few minutes. However, malnourished children are weak and quickly become exhausted, so they may not take enough fluid voluntarily. If this occurs, the solution should be given by nasogastric tube.",
"   </p>",
"   <p>",
"    If adequate rehydration cannot be achieved through oral or nasogastric administration of ReSoMal alone, intravenous fluids may be given. Half-strength Darrow's solution with 5 percent glucose is preferred [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/1\">",
"     1",
"    </a>",
"    ]; the half-strength solution is created by diluting full-strength Darrow&rsquo;s solution (",
"    <a class=\"graphic graphic_table graphicRef51000 \" href=\"UTD.htm?12/6/12395\">",
"     table 6",
"    </a>",
"    ) with an equal amount of 5 percent dextrose in water (D5W). It is also acceptable to use Lactated Ringer's solution with 5 percent glucose or half normal saline, but these solutions should be supplemented with sterile",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/17/11542?source=see_link\">",
"     potassium chloride",
"    </a>",
"    , 20",
"    <span class=\"nowrap\">",
"     mmol/L.",
"    </span>",
"    As mentioned above, hydration via the intravenous route should be approached cautiously, since children with malnutrition are at risk for overhydration and heart failure. The initial bolus should be no more than 15",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    over one hour. If there are signs of improvement (decrease in pulse and respiration rates), then a second bolus of 15",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    may be given if the child is still unable to take this volume by mouth. If the child does not improve after the first bolus, he or she may be suffering from shock rather than dehydration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32248?source=see_link&amp;anchor=H13#H13\">",
"     \"Malnutrition in developing countries: Clinical assessment\", section on 'Distinguishing sepsis from dehydration'",
"    </a>",
"    .) &nbsp; &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Volume replacement",
"    </span>",
"    &nbsp;&mdash;&nbsp;A volume of 70 to 100",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    body weight of ReSoMal usually is enough to restore normal hydration. This amount should be given over the course of 12 hours, starting with 5",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    every 30 minutes for the first two hours, and then 5 to 10",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per hour. This rate is slower than the rate of rehydration for children without severe malnutrition.",
"   </p>",
"   <p>",
"    The child should be assessed at least hourly. The volume administered depends upon the amount the child will drink, the volume of ongoing losses in stool",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    emesis, and any signs of overhydration, especially heart failure. Oral rehydration should be stopped if an increase in respiratory",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pulse rates, engorgement of the jugular veins, or increasing edema (eg, puffy eyelids) occurs.",
"   </p>",
"   <p>",
"    Rehydration is complete when the child no longer is thirsty and produces urine, and signs of dehydration have resolved. Fluids given to maintain hydration should be based upon the child's willingness to drink and the amount of ongoing losses in the stool. As a guide, children younger than two years of age should be given 50 to 100 mL (between one-fourth and one-half of a large cup) of ReSoMal after each loose stool; older children should receive 100 to 200 mL. This treatment is continued until the diarrhea stops.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Refeeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Feedings should be reinitiated using a formula containing 75",
"    <span class=\"nowrap\">",
"     kcal/100",
"    </span>",
"    mL (known as F-75 formula) (",
"    <a class=\"graphic graphic_table graphicRef74062 \" href=\"UTD.htm?33/57/34716\">",
"     table 7",
"    </a>",
"    ). Standard commercial infant formulas can be used if available but may need potassium supplementation, since they only contain 20",
"    <span class=\"nowrap\">",
"     mEq/liter",
"    </span>",
"    of potassium, rather than the 40",
"    <span class=\"nowrap\">",
"     mEq/liter",
"    </span>",
"    found in F-75. The energy intake should equal approximately 80",
"    <span class=\"nowrap\">",
"     kcal/kg",
"    </span>",
"    per day and not exceed 100",
"    <span class=\"nowrap\">",
"     kcal/kg.",
"    </span>",
"    The formula is fed in small amounts and at frequent intervals because intestinal motility and gastric acid production are decreased in severe malnutrition (",
"    <a class=\"graphic graphic_table graphicRef77579 graphicRef54640 graphicRef62304 \" href=\"UTD.htm?23/19/23870\">",
"     table 2A-C",
"    </a>",
"    ). Infants can be fed orally using a cup and spoon; a dropper or syringe can be used in weaker infants. Feeding also should be given by nasogastric tube if the child has impaired consciousness or has vomiting, tachypnea, or painful stomatitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     REHABILITATION PHASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rehabilitation phase begins as the appetite improves. At this time, the formula is gradually changed to F-100, which contains 100",
"    <span class=\"nowrap\">",
"     kcal/100",
"    </span>",
"    mL (",
"    <a class=\"graphic graphic_table graphicRef74062 \" href=\"UTD.htm?33/57/34716\">",
"     table 7",
"    </a>",
"    ). Again, the standard commercial tube feeding formulas (30",
"    <span class=\"nowrap\">",
"     kcal/oz)",
"    </span>",
"    can be used if available, but potassium will need to be supplemented since they only contain about 35",
"    <span class=\"nowrap\">",
"     mEq/liter",
"    </span>",
"    rather than the 63",
"    <span class=\"nowrap\">",
"     mEq/liter",
"    </span>",
"    found in F-100. The volume of oral intake is increased slowly to provide 150 to 220",
"    <span class=\"nowrap\">",
"     kcal/kg",
"    </span>",
"    per day. This treatment is continued until the child's weight-for-height Z-score is &gt;&ndash;1. Children older than two years of age can be successfully rehabilitated using the same formulas that are given to infants. However, in these patients, locally available solid foods supplemented with vitamin and mineral mixes should be introduced. A modified rehabilitation feed, which can be formulated from whole milk, can be seen in the table (",
"    <a class=\"graphic graphic_table graphicRef68248 \" href=\"UTD.htm?20/32/21004\">",
"     table 8",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The child should be fed at least five times daily during the rehabilitation phase. Feeding frequency can be decreased to three times daily when the child attains -1 SD of the median WHO reference values (available at",
"    <a class=\"external\" href=\"file://www.cdc.gov/growthcharts\">",
"     www.cdc.gov/growthcharts",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/2,14\">",
"     2,14",
"    </a>",
"    ]. The adjustment of feeding frequency should take place under supervision before discharge. It is done by gradually reducing and then stopping the supplementary feeds of F-100 while adding or increasing the mixed diet until the child is eating a diet similar to what will be eaten at home.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Dietary supplements",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dietary supplements of vitamins and minerals that are begun during initial management are continued in the rehabilitation phase using the WHO vitamin mix (",
"    <a class=\"graphic graphic_table graphicRef71032 \" href=\"UTD.htm?7/17/7452\">",
"     table 9",
"    </a>",
"    ). Providing supplementation with vitamin A, iron, and folate is especially important [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/1,15\">",
"     1,15",
"    </a>",
"    ]. Multivitamins are provided at approximately 1.5 times the dose given to a normal child.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Vitamin A",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severely malnourished children have vitamin A deficiency that can result in blindness if vitamin A is not supplemented during nutritional rehabilitation. Thus, a large dose of Vitamin A should be given on the day of hospital admission [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/1\">",
"     1",
"    </a>",
"    ]. Vitamin A is given orally in a dose according to age: younger than 6 months, 50,000 IU; 6 to 12 months, 100,000 IU; older than 12 months, 200,000 IU.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Iron and folate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nearly all severely malnourished infants have anemia. Supplementation with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/31/22005?source=see_link\">",
"     folic acid",
"    </a>",
"    should begin on the day of admission (initial dose 5 mg, followed by 1 mg daily), in addition to the standard amount in the WHO vitamin mix. Elemental iron (3",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in three divided oral doses) is begun as the rehabilitation phase starts and is continued for three months. Iron should",
"    <strong>",
"     not",
"    </strong>",
"    be given during the initial phase because of the effect of free iron on oxidative stress. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/4/38983?source=see_link\">",
"     \"Micronutrient deficiencies associated with malnutrition in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When making decisions regarding routine prophylactic iron and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/31/22005?source=see_link\">",
"     folic acid",
"    </a>",
"    supplementation of children in developing countries, the local disease patterns and the availability and use of treatment services for common infectious diseases must be considered [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. A controlled trial of routine supplementation of children with iron and folic acid with or without zinc supplementation in Pemba, Zanzibar (a region with a high rate of malaria transmission) was stopped prematurely because of increased morbidity and mortality in the groups receiving iron and folic acid [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/17\">",
"     17",
"    </a>",
"    ]. A similar study in southern Nepal (a region with a low rate of malaria transmission) found no effect of iron and folic acid supplementation on risk of death [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/18\">",
"     18",
"    </a>",
"    ]. For developing areas with high rates of malaria transmission, we suggest that supplementation of iron and folic acid be targeted to children with anemia, and that such children be monitored for the development of malaria and other infections. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=see_link&amp;anchor=H20317292#H20317292\">",
"     \"Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis\", section on 'Immunity and infection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Zinc",
"    </span>",
"    &nbsp;&mdash;&nbsp;Supplemental zinc is included in the WHO rehydration solution and formulas used for refeeding. In addition, children with diarrhea should be treated with supplemental zinc, using doses of 10 to 20 mg daily for 10 to 14 days [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29753?source=see_link\">",
"     \"Zinc deficiency and supplementation in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     FAILURE TO RESPOND",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the WHO treatment guidelines are followed, a severely malnourished child without complications should show definite signs of improvement within a few days, followed by continued progress [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/1\">",
"     1",
"    </a>",
"    ]. Children who fail to respond to treatment may not achieve the initial anticipated rate of improvement (primary failure) or may deteriorate after an initial satisfactory response (secondary failure). When a patient fails to respond to treatment, care practices should be reviewed, and the child should be reevaluated [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/1\">",
"     1",
"    </a>",
"    ]. The objective is to identify a specific cause and to correct the problem.",
"   </p>",
"   <p>",
"    Failure to respond may be due to the treatment environment or the individual patient. The hospital may provide a poor environment for malnourished children. As examples, staff may be insufficient or inadequately trained, scales may be inaccurate, and feedings may be incorrectly prepared.",
"   </p>",
"   <p>",
"    Children may fail to respond to treatment because they have a serious underlying condition. Malnutrition may result from a variety of conditions including unrecognized congenital abnormalities, inborn errors of metabolism, malignancies, immunological diseases, and other diseases of the major organs.",
"   </p>",
"   <p>",
"    Patients may fail to respond because they are fed insufficient food or have a vitamin or mineral deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/15\">",
"     15",
"    </a>",
"    ]. Malabsorption of nutrients or rumination may contribute to lack of improvement.",
"   </p>",
"   <p>",
"    Children who fail to respond to nutritional treatment should be investigated for infection [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/1\">",
"     1",
"    </a>",
"    ]. Malnutrition leads to increased susceptibility to infection because nutritional deficiency results in immunosuppression and often occurs in the setting of a home environment with poor sanitation. The most frequent infections include diarrhea, dysentery, pneumonia, urinary tract infection, otitis media, skin infections, and tuberculosis. Other infections include intestinal worms, malaria, and human immunodeficiency virus (HIV) infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/37/43609?source=see_link\">",
"     \"Persistent diarrhea in children in developing countries\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Review of rehabilitation failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Accurate records should be kept of all children who fail to respond to treatment and of all deaths. Data should include the child's age, sex, date of admission, weight-for-height (or length) on admission, principal diagnoses, and treatment. If the child died, the date and time of death and apparent cause should be noted. These records should be reviewed periodically to identify areas for improvement. The timing of treatment failure or death can be helpful. As an example, deaths that occur within the first two days often are caused by hypoglycemia, unrecognized or mismanaged septic shock, or serious infection, whereas deaths that occur later often are caused by heart failure related to improper fluid management. Optimum practices should result in a case-fatality rate of less than 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     COGNITIVE AND FAMILY REHABILITATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe malnutrition can result in delayed mental and behavioral development [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. This delay likely is caused by significantly reduced brain growth, as assessed by measurement of head circumference, in malnourished compared with well nourished children [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/23\">",
"     23",
"    </a>",
"    ]. The effect on cognition and behavior is the most serious long-term result of malnutrition.",
"   </p>",
"   <p>",
"    Play programs that provide emotional and physical stimulation should start during rehabilitation and continue after discharge. These programs may reduce the risk of the child having some permanent intellectual disability and emotional impairment [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sensory deprivation should be avoided [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/1\">",
"     1",
"    </a>",
"    ]. The child should be able to see and hear what is happening around him or her. He or she should never be restrained, and the face should not be covered. The mother or an alternate caregiver should stay with the child in the hospital and during rehabilitation. She should be encouraged to feed, hold, comfort, and play with her child as much as possible.",
"   </p>",
"   <p>",
"    Children undergoing treatment for malnutrition should receive care in a cheerful environment. Toys should be available that are appropriate for the child's age and level of development. Play with other children is an important component of rehabilitation. Mothers should be encouraged to participate and can be trained to supervise play sessions.",
"   </p>",
"   <p>",
"    Physical activity should be encouraged to promote the development of essential motor skills and enhance growth. Patients who are unable to move may benefit from passive motion of the limbs. As the child's nutritional status and general condition improve, the duration and intensity of physical activities should increase.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Parent education",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parents should receive education regarding the causes of malnutrition and its prevention. Breast feeding is a particularly important and practical measure to prevent malnutrition, so all mothers should be educated to breast feed future infants whenever possible. Parents should also be given education about an appropriate diet and sanitary feeding techniques, strategies to stimulate the child's mental and emotional development, and other parenting skills. Teaching should begin well before discharge. The mother should spend as much time as possible at the nutrition rehabilitation center with her child, and should provide care, including food preparation, for her child under supervision. She should be taught how to treat, or obtain treatment for, diarrhea and other infections, and to understand the importance of regular treatment for intestinal parasites.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     DISCHARGE PHASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;During rehabilitation, preparations should be made to ensure that the child is fully reintegrated into the family and community after discharge. The family must be prepared to prevent recurrence of severe malnutrition. If possible, the home should be evaluated by a social worker or nurse before discharge to ensure an adequate environment. If the child is abandoned or conditions at the home are unsuitable, a foster home should be sought [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Discharge criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;A child is considered ready for discharge when his or her weight-for-height has reached -1 SD (90 percent) of the median WHO reference values (",
"    <a class=\"graphic graphic_table graphicRef79197 \" href=\"UTD.htm?3/42/3756\">",
"     table 10",
"    </a>",
"    ), corresponding to approximately 15 to 20 percent weight gain [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. Others have suggested use of mid-arm muscle circumference of &gt;12.5 cm as a discharge criteria, which typically represents a larger weight gain [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/24\">",
"     24",
"    </a>",
"    ]. To achieve one or all of these thresholds for discharge, the child should eat four to six meals daily. Some children may be discharged before the target weight-for-height has been reached. In these cases, continued outpatient care is needed through full recovery.",
"   </p>",
"   <p>",
"    Other discharge criteria include completed treatment of all nutritional deficiencies and infections, and initiation or continuation of the standard immunization schedule (",
"    <a class=\"graphic graphic_table graphicRef79197 \" href=\"UTD.htm?3/42/3756\">",
"     table 10",
"    </a>",
"    ). The mother or caregiver should be willing to care for the child. She should be able to provide food, appropriate toys, and initial treatment for diarrhea and infections. A health worker should be available to provide follow-up of the child and support for the mother [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/56/39818?source=see_link&amp;anchor=H2#H2\">",
"     \"Standard immunizations for children and adolescents\", section on 'Overview'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     COMMUNITY-BASED THERAPEUTIC CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;International consensus guidelines now recommend community-based care for children with",
"    <strong>",
"     uncomplicated",
"    </strong>",
"    severe acute malnutrition [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/25\">",
"     25",
"    </a>",
"    ]. Uncomplicated severe acute malnutrition is characterized by good appetite at enrollment and no clinical signs of sepsis, and represents the vast majority of children with malnutrition who present for care [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/26\">",
"     26",
"    </a>",
"    ]. Details of the approach, a field manual, current programs, and outcomes are available through",
"    <a class=\"external\" href=\"file://www.validinternational.org/demo/ctc/about.php\">",
"     Valid International",
"    </a>",
"    and the",
"    <a class=\"external\" href=\"file://www.who.int/nutrition/publications/severemalnutrition/978-92-806-4147-9_eng.pdf\">",
"     World Health Organization",
"    </a>",
"    (WHO) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/25,27,28\">",
"     25,27,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Rationale",
"    </span>",
"    &nbsp;&mdash;&nbsp;The WHO approach to treatment of severe acute malnutrition in an inpatient feeding center, as described above, is often limited by cost, inadequate supply of trained medical personnel, and poor access to health care facilities for many populations. As a result, many of the 13 million children with malnutrition are not treated [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Community-based therapeutic care (CTC) provides a different approach to treatment for malnutrition, emphasizing a decentralized and low-cost model of care. CTC is not limited by adequacy of local health care services. Key components of the CTC approach are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Decentralized design and community involvement, to minimize geographic barriers and encourage early presentation and compliance.",
"     </li>",
"     <li>",
"      Early intervention for moderate acute malnutrition, to prevent progression.",
"     </li>",
"     <li>",
"      Use of simple protocols and supplies, including Ready to Use Therapeutic Food (RUTF), which often can be produced locally.",
"     </li>",
"     <li>",
"      Integrated approach allowing for smooth transitions between inpatient care for children with complicated severe acute malnutrition, and outpatient care for children without complications.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Between 2001 and 2005, an increasing number of countries and relief agencies adopted this approach with remarkable success. Children with severe malnutrition, with or without edema but with a good appetite, were effectively treated as outpatients; children with anorexia or complications were initially treated in inpatient programs [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/29\">",
"     29",
"    </a>",
"    ]. Recovery rates were nearly 80 percent, case fatality rates were 4.1 percent and, thus, equivalent to the rates on the WHO protocol, but \"coverage\" rates (ability to reach the population in need) were increased to 72 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/29,31,32\">",
"     29,31,32",
"    </a>",
"    ]. As a result, CTC has become the preferred approach for emergency relief programs. The approach is also increasingly adopted for larger nonemergency programs, such as those in Malawi and Ethiopia [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/33,34\">",
"     33,34",
"    </a>",
"    ], and is now recommended by the WHO for uncomplicated cases of severe acute malnutrition [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/25,35\">",
"     25,35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28885630\">",
"    <span class=\"h2\">",
"     Key strategies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Key CTC strategies are outpatient treatment with RUTF and a brief empiric course of antibiotics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28885637\">",
"    <span class=\"h3\">",
"     Ready to Use Therapeutic Food (RUTF)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The CTC approach requires food supplements that are of high nutritional quality, inexpensive, easily transportable, and have minimal spoilage. During the 1990s, an effective RUTF was developed from a mixture of peanuts, sugar, oil, and powdered milk, supplemented with a vitamin and mineral mixture. The nutrient profile is similar to that of the F100 diet, but the energy density of RUTF is fourfold higher (",
"    <a class=\"graphic graphic_table graphicRef82277 \" href=\"UTD.htm?32/22/33133\">",
"     table 11",
"    </a>",
"    ). Because of low water content, RUTF can be kept unrefrigerated for several months and is thus ideal for outpatient use. In a randomized trial in severely malnourished children in Senegal, children treated with RUTF recovered more quickly than children treated with F100 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The RUTF mixture is available commercially in the form of bars, under the brand name Plumpy'nut&reg;. It also can be prepared as a paste made from locally available foods with the addition of powdered milk and a commercially available vitamin and mineral mixture [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/37\">",
"     37",
"    </a>",
"    ]. Newer formulations substitute locally available sources of protein (eg, sesame paste) and grain (rice, maize, sorghum, or barley) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/38\">",
"     38",
"    </a>",
"    ]. In a randomized trial, addition of probiotic bacteria and prebiotic fiber to RUTF did not alter the frequency or speed of nutritional cure, frequency of diarrhea or other clinical symptoms, or cumulative mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/39\">",
"     39",
"    </a>",
"    ]. RUTF is provided at doses of approximately 175 kcal (733",
"    <span class=\"nowrap\">",
"     J)/kg/day.",
"    </span>",
"    Children who display a good appetite by consuming RUTF in the ambulatory care facility are good candidates for outpatient treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28885677\">",
"    <span class=\"h3\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend a brief empiric course of oral antibiotics (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/49/34583?source=see_link\">",
"     amoxicillin",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/2/6181?source=see_link\">",
"     cefdinir",
"    </a>",
"    for seven days) for children treated for uncomplicated severe acute malnutrition in an outpatient setting [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/25\">",
"     25",
"    </a>",
"    ]. This practice was initially suggested by the WHO based primarily on expert opinion and observations of the high rates of clinically significant infections among hospitalized children with severe acute malnutrition [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/40,41\">",
"     40,41",
"    </a>",
"    ], but the evidence base was weak and somewhat contradictory [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. The practice is now supported by a prospective randomized trial in 2767 children in Malawi, who were treated with a seven-day course of amoxicillin, cefdinir, or placebo in addition to nutritional rehabilitation with RUTF [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/44\">",
"     44",
"    </a>",
"    ]. Either amoxicillin or cefdinir improved recovery rates, time to recovery, and weight gain as compared to placebo. Moreover, treatment with antibiotics reduced mortality, from 7.4 percent among children treated with placebo, to 4.8 percent among those treated with amoxicillin or 4.1 percent among those treated with cefdinir. &nbsp; &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18939235\">",
"    <span class=\"h1\">",
"     COMMUNITY-BASED PREVENTIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Effective preventive care requires recognition of children at risk for severe malnutrition and implementation of interventions to arrest progression to the severely malnourished state. The following review of strategies and recommendations for preventing malnutrition may be beneficial to the local practitioner in countries with substandard child growth and development.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18939242\">",
"    <span class=\"h2\">",
"     Recognition of at risk populations",
"    </span>",
"    &nbsp;&mdash;&nbsp;In developed countries, severe malnutrition is usually caused by an underlying chronic illness. By contrast, in resource-limited settings, both food insecurity and an acute treatable illness contribute to malnutrition. In many cases, malnutrition can be prevented by treating the underlying illness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18939249\">",
"    <span class=\"h3\">",
"     Diarrheal illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic or prolonged diarrhea is a common risk factor for the development of severe malnutrition. Isolated diarrheal illnesses (duration &lt;14 days) usually do not a cause more than transient slowing of growth [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/45\">",
"     45",
"    </a>",
"    ]. However in the setting of under-nutrition, the intestinal mucosa does not efficiently regenerate. This leads to persistent diarrhea, which in turn contributes to the malnutrition by causing malabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/46\">",
"     46",
"    </a>",
"    ]. Thus, the prevention and treatment of diarrheal illnesses through standard sanitary measures becomes an essential foundation for local efforts to prevent malnutrition. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/37/43609?source=see_link&amp;anchor=H4#H4\">",
"     \"Persistent diarrhea in children in developing countries\", section on 'Pathophysiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18939256\">",
"    <span class=\"h3\">",
"     Malaria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Micronutrient deficiencies (ie, vitamin A, zinc, iron, folate) and impaired immune response related to these deficiencies are important contributors to the morbidity and mortality associated with malaria [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/47\">",
"     47",
"    </a>",
"    ]. Conversely, several studies have shown that improved nutritional status lessens the morbidity associated with malaria episodes and results in fewer malaria-related deaths. The prevention of malnutrition, particularly micronutrient deficiencies, is an integral component of malaria intervention programs [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/26/5543?source=see_link\">",
"     \"Clinical manifestations of malaria\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18939263\">",
"    <span class=\"h3\">",
"     HIV",
"    </span>",
"    &nbsp;&mdash;&nbsp;The association between human immunodeficiency virus (HIV) infection and malnutrition is complex. The immunologic compromise caused by HIV infection accelerates comorbid disease processes (such as tuberculosis, malaria, or chronic diarrhea) that cause increased metabolic demands and malnutrition. Many of these diseases also contribute to the immunosuppression. In patients with HIV infection, treatment with appropriate anti-retroviral (ARV) drugs and treatment or prevention of associated infections are essential steps to prevent or treat malnutrition [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/49\">",
"     49",
"    </a>",
"    ]. In addition, children with HIV infection require adequate nutritional supplementation to meet their increased metabolic needs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/3/3130?source=see_link\">",
"     \"Natural history and classification of pediatric HIV infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18939270\">",
"    <span class=\"h2\">",
"     Supplementation strategies for prevention of malnutrition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Throughout the 20th century, food distribution measures were implemented in a variety of contexts to combat food insecurity and malnutrition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30499444\">",
"    <span class=\"h3\">",
"     Generalized food distribution",
"    </span>",
"    &nbsp;&mdash;&nbsp;The usual approach to food crises has been to organize a generalized food distribution (GFD), in which daily food rations (typically an allotment of a cereal item) are distributed to all members of a population. Although helpful as a first line strategy during a crisis, GFD schemes usually fail to prevent malnutrition because they do not target risk groups within a population who would benefit most from nutrition support [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/50-52\">",
"     50-52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18939277\">",
"    <span class=\"h3\">",
"     Targeted supplementation strategies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the poor efficacy of GFD schemes, the WHO now endorses supplementation strategies that target at-risk subgroups as the best strategy for preventing malnutrition within a population experiencing food insecurity. &nbsp;",
"   </p>",
"   <p>",
"    Targeted childhood supplemental feeding programs directly supplement those populations and age groups at the greatest risk for malnutrition, usually nursing mothers and children younger than 60 months. Current recommendations emphasize protein and lipid rich food items, such as Ready to Use Therapeutic Food (RUTF) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/25,35\">",
"     25,35",
"    </a>",
"    ], in contrast to previous strategies which relied on grain-based foods.",
"   </p>",
"   <p>",
"    RUTF supplements provide a supplement that is readily transportable and sanitary, with a relatively long shelf life without refrigeration. Multiple studies have established the efficacy of RUTFs as a therapeutic strategy for children with moderate to severe malnutrition, as outlined above (see",
"    <a class=\"local\" href=\"#H28885637\">",
"     'Ready to Use Therapeutic Food (RUTF)'",
"    </a>",
"    above). Additional interest has been focused on whether use of RUTF in children who are already exhibiting stunting may prevent progression to more severe forms of malnutrition. A single study in Niger evaluated the use of RUTF for children with moderate acute malnutrition and suggested modest benefit as compared with treatment with a more traditional supplementation strategy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/53\">",
"     53",
"    </a>",
"    ]. Additional questions of composition and cost also come into consideration when considering the use of RUTFs within a resource limited setting [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/50-52\">",
"     50-52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18939284\">",
"    <span class=\"h1\">",
"     OTHER STRATEGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Strategies to promote breastfeeding substantially improve infant survival but have little effect on preventing stunting. In populations with insufficient food, provision of complimentary weaning supplements increased the height-for-age by 41 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/54\">",
"     54",
"    </a>",
"    ]. Theoretical models using this data suggest that a combination of several interventions designed to improve nutrition and prevent related disease could reduce stunting at three years of age by 36 percent.",
"   </p>",
"   <p>",
"    Until adequate community research has been conducted and meaningful and successful ways of ensuring nutrient security for families are achieved, we will need to rely on fortified food supplements that have been such a success for preventing all forms of malnutrition [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/52\">",
"     52",
"    </a>",
"    ]. From a global perspective, elimination of stunting must be complimented by improvements of the underlying structural determinants of malnutrition: poverty, poor education, disease burden, and lack of women's empowerment [",
"    <a class=\"abstract\" href=\"UTD.htm?8/61/9178/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17439035\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Severely malnourished children typically are brought to medical attention when a health crisis, such as an infection, precipitates the transition between marasmus (a state of nutritional adaptation) and kwashiorkor, in which adaptation is no longer adequate.",
"     </li>",
"     <li>",
"      Malnutrition is categorized based upon the degree of wasting or stunting and the presence of edema (",
"      <a class=\"graphic graphic_table graphicRef60869 \" href=\"UTD.htm?12/59/13244\">",
"       table 1",
"      </a>",
"      ). The child's weight for height, and the height for age are expressed as Z-scores (also known as the standard deviation [SD] score). The degree of malnutrition can be determined by plotting the height and weight on Z-score charts. Charts based on recumbent length are used for children up to two years of age (",
"      <a class=\"graphic graphic_figure graphicRef64985 graphicRef76745 graphicRef77428 graphicRef56424 \" href=\"UTD.htm?32/40/33418\">",
"       figure 1A-D",
"      </a>",
"      ), and charts based on standing height are used for those between two and five years (",
"      <a class=\"graphic graphic_figure graphicRef53829 graphicRef64531 graphicRef56071 graphicRef67900 \" href=\"UTD.htm?31/40/32394\">",
"       figure 2A-D",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Classification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of a malnourished child begins with a stabilization phase, emphasizing treatment of hypoglycemia, hypothermia, and dehydration, and the detection and treatment of infection. Feedings are begun in this period, and electrolytes and vitamins are replaced, except for iron. The rehabilitation phase lasts two to six weeks and consists of advancing nutrition, ongoing vitamin supplementation with the addition of iron, and training of the parent for follow-up care (",
"      <a class=\"graphic graphic_figure graphicRef76855 \" href=\"UTD.htm?1/6/1134\">",
"       figure 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'WHO management guidelines'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For the initial treatment of children with severe malnutrition, we recommend empiric treatment with broad-spectrum antibiotics rather than no treatment (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ), because many children with severe malnutrition have systemic infections. Blood cultures should be obtained, but treatment should be initiated while awaiting results. Typical treatment regimens for children with no apparent complications are",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/23/41336?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      orally for five days. For children with symptoms suggesting complications such as hypoglycemia, hypothermia, or lethargy, we recommend intravenous antibiotics such as the combination of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"       gentamicin",
"      </a>",
"      rather than oral antibiotics (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Antibiotics'",
"      </a>",
"      above.) &nbsp; &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      Dehydration in the malnourished child should be differentiated from septic shock and treated with oral rather than intravenous rehydration when possible to reduce the risk of overhydration and heart failure. The optimal solution for initial rehydration is ReSoMal, which is based on the standard WHO rehydration oral solution that has been modified by decreasing sodium and increasing potassium concentrations (",
"      <a class=\"graphic graphic_table graphicRef53739 \" href=\"UTD.htm?20/0/20491\">",
"       table 4",
"      </a>",
"      ). A total of about 70 to 100",
"      <span class=\"nowrap\">",
"       mL/kg",
"      </span>",
"      body weight should be given during the first 12 hours of treatment. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Rehydration'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'ReSoMal'",
"      </a>",
"      above.) &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      After rehydration is complete, feedings should be initiated using a formula containing 75",
"      <span class=\"nowrap\">",
"       kcal/100",
"      </span>",
"      mL (F-75) (",
"      <a class=\"graphic graphic_table graphicRef74062 \" href=\"UTD.htm?33/57/34716\">",
"       table 7",
"      </a>",
"      ). Standard commercial infant formulas can be used if available but may need potassium supplementation. The energy intake should be approximately 80",
"      <span class=\"nowrap\">",
"       kcal/kg",
"      </span>",
"      per day and should not exceed 100",
"      <span class=\"nowrap\">",
"       kcal/kg.",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Refeeding'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      After the child's appetite improves (usually after about one week), the child enters the rehabilitation phase, and feedings are advanced to a formula containing 100",
"      <span class=\"nowrap\">",
"       kcal/100",
"      </span>",
"      mL (F-100). The child should be fed at least five times daily, and goals for intake are 150 to 220",
"      <span class=\"nowrap\">",
"       kcal/kg",
"      </span>",
"      body weight daily. Children older than two years of age can be successfully rehabilitated using the same formulas that are given to infants, with the addition of locally available solid foods supplemented with vitamin and mineral mixes. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Rehabilitation phase'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dietary supplements of vitamins and minerals that are begun during initial management are continued in the rehabilitation phase using the WHO vitamin mix (",
"      <a class=\"graphic graphic_table graphicRef71032 \" href=\"UTD.htm?7/17/7452\">",
"       table 9",
"      </a>",
"      ). Multivitamins are provided at approximately 1.5 times the dose given to a normal child. Supplementation with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/31/22005?source=see_link\">",
"       folic acid",
"      </a>",
"      and other vitamins except iron are begun on admission; iron supplements are added as the rehabilitation phase begins. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Dietary supplements'",
"      </a>",
"      above.) &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      For children with",
"      <strong>",
"       uncomplicated",
"      </strong>",
"      severe acute malnutrition, which is characterized by good appetite at enrollment and no clinical signs of sepsis, international consensus guidelines support community-based outpatient care. Community-based therapeutic care (CTC) is a decentralized and low-cost model of intervention that may be a more practical approach to malnutrition in the developing world. Malnutrition is treated or prevented through generalized food distribution or more effectively with targeted supplementation strategies. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Community-based therapeutic care'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The main form of nutritional supplement used in these community-based programs is Ready to Feed Therapeutic Food (RUTF). (See",
"      <a class=\"local\" href=\"#H28885637\">",
"       'Ready to Use Therapeutic Food (RUTF)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children treated in this setting, we recommend a routine course of oral antibiotics (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Either",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/49/34583?source=see_link\">",
"       amoxicillin",
"      </a>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/2/6181?source=see_link\">",
"       cefdinir",
"      </a>",
"      for seven days was successfully used in a clinical trial. (See",
"      <a class=\"local\" href=\"#H28885677\">",
"       'Antibiotics'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18939625\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The authors of this topic review would like to acknowledge Dr. Thaddaeus May, who researched some of this topic&rsquo;s content.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Management of severe malnutrition: a manual for physicians and other senior health workers, WHO, Geneva 1999. www.who.int/nutrition/publications/malnutrition/en/index.html (Accessed on November 17, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/2\">",
"      WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards based on length/height, weight and age. Acta Paediatr Suppl 2006; 450:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/3\">",
"      de Onis M, Garza C, Onyango AW, Borghi E. Comparison of the WHO child growth standards and the CDC 2000 growth charts. J Nutr 2007; 137:144.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization (WHO) and United Nations Children's Fund (UNICEF). WHO child growth standards and the identification of severe acute malnutrition in infants and children. World Health Organization Press; Department of Child and Adolescent Health and Development, Geneva, 2009.",
"    </li>",
"    <li>",
"     Ashworth A, Khanum S, Jackson A, Schofield C. Guidelines for the inpatient treatment of severely malnourished children. World Health Organization, Geneva, 2003. Available at: file://www.who.int/nutrition/publications/severemalnutrition/9241546093_eng.pdf.",
"    </li>",
"    <li>",
"     Saitoria, EP, Mswata, A, Sanders, D, et al. Treating severe Malnutrition. Child Health Dialogue 2000:19 www.healthlink.org.uk/PDFs/chd19.pdf (Accessed on September 13, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/7\">",
"      Puoane T, Sanders D, Ashworth A, et al. Improving the hospital management of malnourished children by participatory research. Int J Qual Health Care 2004; 16:31.",
"     </a>",
"    </li>",
"    <li>",
"     Ashworth A. The impact of the TMRU on the treatment of severe malnutrition. In: The Tropical 18. Metabolism Research Unit, The University of the West Indies, Jamaica, Forrester T, Picou D, Walker S (Eds), Ian Randle Publishers, Kingston 2006. p.285.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/9\">",
"      Wharton B. Hypoglycaemia in children with kwashiorkor. Lancet 1970; 1:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/10\">",
"      Reed RP, Wegerhoff FO, Rothberg AD. Bacteraemia in malnourished rural African children. Ann Trop Paediatr 1996; 16:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/11\">",
"      Friedland IR. Bacteraemia in severely malnourished children. Ann Trop Paediatr 1992; 12:433.",
"     </a>",
"    </li>",
"    <li>",
"     Management of the child with a serious infection or severe malnutrition: guidelines for care at first referral level in developing countries. Geneva, World Health Organization, 2000.",
"    </li>",
"    <li>",
"     The treatment of diarrhea: A manual for physicians and other senior health workers, WHO 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/14\">",
"      Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002; 109:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/15\">",
"      Collins S, Myatt M, Golden B. Dietary treatment of severe malnutrition in adults. Am J Clin Nutr 1998; 68:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/16\">",
"      English M, Snow RW. Iron and folic acid supplementation and malaria risk. Lancet 2006; 367:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/17\">",
"      Sazawal S, Black RE, Ramsan M, et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006; 367:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/18\">",
"      Tielsch JM, Khatry SK, Stoltzfus RJ, et al. Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: community-based, cluster-randomised, placebo-controlled trial. Lancet 2006; 367:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/19\">",
"      Ojukwu JU, Okebe JU, Yahav D, Paul M. Oral iron supplementation for preventing or treating anaemia among children in malaria-endemic areas. Cochrane Database Syst Rev 2009; :CD006589.",
"     </a>",
"    </li>",
"    <li>",
"     The treatment of diarrhea; A manual for physicians and other senior health workers, WHO, Geneva 2005 file://www.who.int/child_adolescent_health/documents/9241593180/en/index.html (Accessed on November 17, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/21\">",
"      Grantham-McGregor SM, Stewart M, Desai P. A new look at the assessment of mental development in young children recovering from severe malnutrition. Dev Med Child Neurol 1978; 20:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/22\">",
"      Grantham-McGregor SM. Assessments of the effects of nutrition on mental development and behavior in Jamaican studies. Am J Clin Nutr 1993; 57:303S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/23\">",
"      Oyedeji GA, Olamijulo SK, Osinaike AI, et al. Head circumference of rural Nigerian children--the effect of malnutrition on brain growth. Cent Afr J Med 1997; 43:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/24\">",
"      Dale NM, Myatt M, Prudhon C, Briend A. Using mid-upper arm circumference to end treatment of severe acute malnutrition leads to higher weight gains in the most malnourished children. PLoS One 2013; 8:e55404.",
"     </a>",
"    </li>",
"    <li>",
"     Community-based management of severe acute malnutrition. A joint statement by the World Health Organization, the World Food Programme, the United Nations System Standing Committee on Nutrition, and the United Nations Children's Fund, 2007. Available at: file://www.who.int/nutrition/publications/severemalnutrition/978-92-806-4147-9_eng.pdf (Accessed on August 11, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/26\">",
"      Manary MJ, Sandige HL. Management of acute moderate and severe childhood malnutrition. BMJ 2008; 337:a2180.",
"     </a>",
"    </li>",
"    <li>",
"     Valid International file://www.validinternational.org/demo/ctc/about.php (Accessed on February 01, 2013).",
"    </li>",
"    <li>",
"     Community-based therapeutic care - A field manual. Valid international, Oxford, U.K. www.validinternational.org (Accessed on September 13, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/29\">",
"      Collins S. Treating severe acute malnutrition seriously. Arch Dis Child 2007; 92:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/30\">",
"      Schofield C, Ashworth A. Why have mortality rates for severe malnutrition remained so high? Bull World Health Organ 1996; 74:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/31\">",
"      Collins S, Dent N, Binns P, et al. Management of severe acute malnutrition in children. Lancet 2006; 368:1992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/32\">",
"      Ciliberto MA, Manary MJ, Ndekha MJ, et al. Home-based therapy for oedematous malnutrition with ready-to-use therapeutic food. Acta Paediatr 2006; 95:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/33\">",
"      Gatchell V, Forsythe V, Thomas PR. The sustainability of community-based therapeutic care (CTC) in nonemergency contexts. Food Nutr Bull 2006; 27:S90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/34\">",
"      Ndekha MJ, Manary MJ, Ashorn P, Briend A. Home-based therapy with ready-to-use therapeutic food is of benefit to malnourished, HIV-infected Malawian children. Acta Paediatr 2005; 94:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/35\">",
"      Prudhon C, Prinzo ZW, Briend A, et al. Proceedings of the WHO, UNICEF, and SCN Informal Consultation on Community-Based Management of Severe Malnutrition in Children. Food Nutr Bull 2006; 27:S99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/36\">",
"      Diop el HI, Dossou NI, Ndour MM, et al. Comparison of the efficacy of a solid ready-to-use food and a liquid, milk-based diet for the rehabilitation of severely malnourished children: a randomized trial. Am J Clin Nutr 2003; 78:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/37\">",
"      Manary MJ. Local production and provision of ready-to-use therapeutic food (RUTF) spread for the treatment of severe childhood malnutrition. Food Nutr Bull 2006; 27:S83.",
"     </a>",
"    </li>",
"    <li>",
"     Collins, S, Henry, J. Alternative RUTF formulations. Emergency Nutrition Network 2004; special supplement 2:35. www.validinternational.org/pages/sub.cfm?id=1663 (Accessed on May 24, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/39\">",
"      Kerac M, Bunn J, Seal A, et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double-blind efficacy randomised controlled trial in Malawi. Lancet 2009; 374:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/40\">",
"      Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 2005; 352:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/41\">",
"      Siga&uacute;que B, Roca A, Mandomando I, et al. Community-acquired bacteremia among children admitted to a rural hospital in Mozambique. Pediatr Infect Dis J 2009; 28:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/42\">",
"      Lazzerini M, Tickell D. Antibiotics in severely malnourished children: systematic review of efficacy, safety and pharmacokinetics. Bull World Health Organ 2011; 89:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/43\">",
"      Trehan I, Amthor RE, Maleta K, Manary MJ. Evaluation of the routine use of amoxicillin as part of the home-based treatment of severe acute malnutrition. Trop Med Int Health 2010; 15:1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/44\">",
"      Trehan I, Goldbach HS, LaGrone LN, et al. Antibiotics as part of the management of severe acute malnutrition. N Engl J Med 2013; 368:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/45\">",
"      Lutter CK, Mora JO, Habicht JP, et al. Nutritional supplementation: effects on child stunting because of diarrhea. Am J Clin Nutr 1989; 50:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/46\">",
"      Guerrant RL, Ori&aacute; RB, Moore SR, et al. Malnutrition as an enteric infectious disease with long-term effects on child development. Nutr Rev 2008; 66:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/47\">",
"      Mbugi EV, Meijerink M, Veenemans J, et al. Effect of nutrient deficiencies on in vitro Th1 and Th2 cytokine response of peripheral blood mononuclear cells to Plasmodium falciparum infection. Malar J 2010; 9:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/48\">",
"      Caulfield LE, Richard SA, Black RE. Undernutrition as an underlying cause of malaria morbidity and mortality in children less than five years old. Am J Trop Med Hyg 2004; 71:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/49\">",
"      de Pee S, Semba RD. Role of nutrition in HIV infection: review of evidence for more effective programming in resource-limited settings. Food Nutr Bull 2010; 31:S313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/50\">",
"      Rah JH, Akhter N, Semba RD, et al. Low dietary diversity is a predictor of child stunting in rural Bangladesh. Eur J Clin Nutr 2010; 64:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/51\">",
"      Sari M, de Pee S, Bloem MW, et al. Higher household expenditure on animal-source and nongrain foods lowers the risk of stunting among children 0-59 months old in Indonesia: implications of rising food prices. J Nutr 2010; 140:195S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/52\">",
"      Golden MH. Evolution of nutritional management of acute malnutrition. Indian Pediatr 2010; 47:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/53\">",
"      Nackers F, Broillet F, Oumarou D, et al. Effectiveness of ready-to-use therapeutic food compared to a corn/soy-blend-based pre-mix for the treatment of childhood moderate acute malnutrition in Niger. J Trop Pediatr 2010; 56:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/61/9178/abstract/54\">",
"      Bhutta ZA, Ahmed T, Black RE, et al. What works? Interventions for maternal and child undernutrition and survival. Lancet 2008; 371:417.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5901 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-B86BBD9DD2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_61_9178=[""].join("\n");
var outline_f8_61_9178=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17439035\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Charts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Calculators",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      WHO MANAGEMENT GUIDELINES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      INITIAL PHASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Warming",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      REHYDRATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      ReSoMal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Rehydration methods",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Volume replacement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Refeeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      REHABILITATION PHASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Dietary supplements",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Vitamin A",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Iron and folate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Zinc",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      FAILURE TO RESPOND",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Review of rehabilitation failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      COGNITIVE AND FAMILY REHABILITATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Parent education",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      DISCHARGE PHASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Discharge criteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      COMMUNITY-BASED THERAPEUTIC CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Rationale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28885630\">",
"      Key strategies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28885637\">",
"      - Ready to Use Therapeutic Food (RUTF)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28885677\">",
"      - Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18939235\">",
"      COMMUNITY-BASED PREVENTIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18939242\">",
"      Recognition of at risk populations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18939249\">",
"      - Diarrheal illness",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18939256\">",
"      - Malaria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18939263\">",
"      - HIV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18939270\">",
"      Supplementation strategies for prevention of malnutrition",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30499444\">",
"      - Generalized food distribution",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18939277\">",
"      - Targeted supplementation strategies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18939284\">",
"      OTHER STRATEGIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17439035\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18939625\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5901\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5901|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/8/17538\" title=\"figure 1A\">",
"      Lngth age boys z 0 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/38/9826\" title=\"figure 1B\">",
"      Lngth age girls z 0 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/50/10019\" title=\"figure 1C\">",
"      Wt length boys z 0 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/2/11299\" title=\"figure 1D\">",
"      Wt length girls z 0 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/56/898\" title=\"figure 2A\">",
"      Ht age boys z 2 5",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/33/5650\" title=\"figure 2B\">",
"      Ht age girls z 2 5",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/0/14339\" title=\"figure 2C\">",
"      Wt height boys z 2 5",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/54/4963\" title=\"figure 2D\">",
"      Wt height girls z 2 5",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/6/1134\" title=\"figure 3\">",
"      Treatment of the severely malnourished child",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5901|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/59/13244\" title=\"table 1\">",
"      WHO classification malnutrition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/17/11549\" title=\"table 2A\">",
"      Physiologic Rx Malnutrition A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/8/30860\" title=\"table 2B\">",
"      Physiologic Rx Malnutrition B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/42/27307\" title=\"table 2C\">",
"      Physiologic Rx Malnutrition C",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/41/34460\" title=\"table 3\">",
"      Dehydration vs septic shock",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/0/20491\" title=\"table 4\">",
"      ReSoMal composition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/38/26219\" title=\"table 5\">",
"      WHO mineral mix",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/6/12395\" title=\"table 6\">",
"      Darrows solution",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/57/34716\" title=\"table 7\">",
"      F-75 and F-100 Diets",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/32/21004\" title=\"table 8\">",
"      Whole milk diets",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/17/7452\" title=\"table 9\">",
"      WHO vitamin mix",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/42/3756\" title=\"table 10\">",
"      WHO discharge criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/22/33133\" title=\"table 11\">",
"      RUTF",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?35/40/36485?source=related_link\" title=\"calculator 1\">",
"      Calculator: WHO Assessment of Malnutrition in Boys 0 to 2 Years Old",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?36/1/36885?source=related_link\" title=\"calculator 2\">",
"      Calculator: WHO Assessment of Malnutrition in Girls 0 to 2 Years Old",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?29/32/30213?source=related_link\" title=\"calculator 3\">",
"      Calculator: WHO Assessment of Malnutrition in Boys 2 to 5 years Old",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?29/48/30469?source=related_link\" title=\"calculator 4\">",
"      Calculator: WHO Assessment of Malnutrition in Girls 2 to 5 years Old",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/26/5543?source=related_link\">",
"      Clinical manifestations of malaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=related_link\">",
"      Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32248?source=related_link\">",
"      Malnutrition in developing countries: Clinical assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/16/30985?source=related_link\">",
"      Management of failure to thrive (undernutrition) in children younger than two years",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/4/38983?source=related_link\">",
"      Micronutrient deficiencies associated with malnutrition in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/3/3130?source=related_link\">",
"      Natural history and classification of pediatric HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/37/43609?source=related_link\">",
"      Persistent diarrhea in children in developing countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/56/39818?source=related_link\">",
"      Standard immunizations for children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/17/17688?source=related_link\">",
"      Treatment of hypovolemia (dehydration) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29753?source=related_link\">",
"      Zinc deficiency and supplementation in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_61_9179="Ranges for corrected QT interval";
var content_f8_61_9179=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F78934&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F78934&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Definition of normal, borderline, and prolonged corrected QT interval (QTc) in seconds according to age and gender",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        1 to 15 yrs",
"       </td>",
"       <td class=\"subtitle1\">",
"        Men",
"       </td>",
"       <td class=\"subtitle1\">",
"        Women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        0.44 sec",
"       </td>",
"       <td>",
"        &lt;0.43 sec",
"       </td>",
"       <td>",
"        &lt;0.45 sec",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Borderline",
"       </td>",
"       <td>",
"        0.44 to 0.46 sec",
"       </td>",
"       <td>",
"        0.43 to 0.45 sec",
"       </td>",
"       <td>",
"        0.45 to 0.47 sec",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prolonged (upper one percent)",
"       </td>",
"       <td>",
"        &gt;0.46 sec",
"       </td>",
"       <td>",
"        &gt;0.45 sec",
"       </td>",
"       <td>",
"        &gt;0.47 sec",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_61_9179=[""].join("\n");
var outline_f8_61_9179=null;
var title_f8_61_9180="IUGR management";
var content_f8_61_9180=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F68553&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F68553&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Evaluation and management of the IUGR fetus",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Constitutionally small fetus",
"       </td>",
"       <td class=\"subtitle1\">",
"        Fetus with structural and/or chromosome abnormality; fetal infection",
"       </td>",
"       <td class=\"subtitle1\">",
"        Substrate deprivation; uteroplacental insuffiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Growth rate and pattern",
"       </td>",
"       <td>",
"        Usually below but parallel to normal; symmetric",
"       </td>",
"       <td>",
"        Markedly below normal; symmetric",
"       </td>",
"       <td>",
"        Variable; usually asymmetric",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anatomy",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Usually abnormal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amniotic fluid volume",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal or hydramnios; decreased in the presence of renal agenesis or urethral obstruction",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Additional evaluation",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        Karyotype; specific testing for viral DNA in amniotic fluid as indicated",
"       </td>",
"       <td>",
"        Fetal lung maturity testing as indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Additional laboratory evaluation of fetal well-being",
"       </td>",
"       <td>",
"        Normal BPP/UAV",
"       </td>",
"       <td>",
"        BPP variable; normal UAV",
"       </td>",
"       <td>",
"        BPP score decreases; UAV shows evidence of vascular resistance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Continued surveillance and timing of delivery",
"       </td>",
"       <td>",
"        None; anticipate term delivery",
"       </td>",
"       <td>",
"        Dependent upon etiology",
"       </td>",
"       <td>",
"        BPP and UAV; delivery timing requires balance of gestational age and BPP/UAV findings; fetal lung maturity testing often helpful",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     IUGR: intrauterine growth restriction; BPP: biophysical profile; UAV: umbilical artery velocimetry.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Resnik, R. Intrauterine Growth Restriction. Obstetrics &amp; Gynecology 2002; 99:490. Copyright &copy; 2002 American College of Obstetrics and Gynecology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_61_9180=[""].join("\n");
var outline_f8_61_9180=null;
var title_f8_61_9181="Major causes of weight loss";
var content_f8_61_9181=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F69495&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F69495&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major causes of weight loss",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Involuntary weight loss with increased appetite",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperthyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Uncontrolled diabetes mellitus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Malabsorption syndromes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Marked increase in physical activity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Involuntary weight loss with decreased appetite",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Medical disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Malignancy (particularly gastrointestinal, lung, lymphoma, renal, and prostate cancers)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Gastrointestinal diseases (including peptic ulcer disease, malabsorption, diabetic enteropathy, dysphagia, inflammatory bowel disease, hepatitis, Zenker's diverticulum, paraesophageal hernia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Endocrine diseases (hyperthyroidism, diabetes, adrenal insufficiency)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Infectious diseases (HIV, viral hepatitis, tuberculosis, chronic fungal or bacterial disease, chronic helminth infection, lung abscess)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Severe heart, lung, or kidney disease (cardiac cachexia from heart failure; pulmonary cachexia from severe obstructive or restrictive lung disease; renal failure, nephrotic sydrome, chronic glomerulonephritis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Neurological diseases (stroke, dementia, dysphagia, Parkinson disease, amyotrophic lateral sclerosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Noninfectious chronic inflammatory diseases (sarcoidosis, severe rheumatoid arthritis, giant cell vasculitis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Psychiatric disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Affective disorders (depression, bipolar disorder, generalized anxiety disorder)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Food-related delusional manifestations of other psychiatric disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Alcohol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Opiates",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Amphetamines and cocaine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Drug withdrawal syndromes (withdrawal after chronic high-dose psychotropic medications or cannabis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Adverse effects of prescription drugs (topiramate, zonisamide, SSRIs, levodopa, digoxin, metformin, exenatide, liraglutide, NSAIDS, and anticancer and antiretroviral drugs)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Herbal and other nonprescription drugs (5-hydroxytryptophan, aloe, caffeine, cascara, chitosan, chromium, dandelion, ephedra, garcinia, glucomannan, guarana, guar gum, herbal diuretics, nicotine, pyruvate, St. John's wort)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Voluntary weight loss",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Prescription drugs used for treating obesity (rimonabant, orlistat, phentermine, sibutramine, metformin, bupropion)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Prescription drugs occasionally abused for weight loss effects (amphetamines and derivatives, thyroid hormone)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Herbal and other nonprescription drugs (5-hydroxytryptophan, aloe, caffeine, cascara, chitosan, chromium, dandelion, ephedra, garcinia, glucomannan, guarana, guar gum, herbal diuretics, nicotine, pyruvate, St. John's wort)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dieting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anorexia nervosa and bulimia nervosa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic vigorous exercise, usually combined with dieting (eg, distance runners, ballet dancers, gymnasts)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_61_9181=[""].join("\n");
var outline_f8_61_9181=null;
var title_f8_61_9182="Rx staph PVE";
var content_f8_61_9182=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F61202&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F61202&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Suggested regimens for therapy of prosthetic valve endocarditis due to staphylococcus",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\" colspan=\"2\">",
"       American Heart Association",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"       European Society of Cardiology",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\">",
"       Adult (for patients with normal renal function)",
"      </td>",
"      <td class=\"subtitle2\">",
"       Pediatric (not to exceed dose of normal adult)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Oxacillin-susceptible strains",
"      </td>",
"      <td class=\"subtitle2_left\">",
"       Oxacillin-susceptible strains",
"      </td>",
"      <td class=\"subtitle2_left\">",
"       Methicillin-susceptible strains",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        <strong>",
"         One of the following:",
"        </strong>",
"       </p>",
"       <p>",
"        Nafcillin or oxacillin* 12 g per 24 h IV in 6 equally divided doses for &ge;6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         or",
"        </strong>",
"       </p>",
"       <p>",
"        Cefazolin&loz; 6 g per 24 h IV in 3 equally divided doses for &ge;6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         or",
"        </strong>",
"       </p>",
"       <p>",
"        Vancomycin&sect;&yen; 30 mg/kg per 24 h IV in 2 equally divided doses for &ge;6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         plus",
"        </strong>",
"       </p>",
"       <p>",
"        Rifampin 900 mg per 24 h IV or PO in 3 equally divided doses for &ge;6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         plus",
"        </strong>",
"       </p>",
"       <p>",
"        Gentamicin&Dagger; 3 mg/kg per 24 h IV or IM in 2 or 3 equally divided doses for 2 wks",
"       </p>",
"      </td>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        <strong>",
"         One of the following:",
"        </strong>",
"       </p>",
"       <p>",
"        Nafcillin or oxacillin* 200 mg/kg per 24 h IV in 4 or 6 equally divided doses for &ge;6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         or",
"        </strong>",
"       </p>",
"       <p>",
"        Cefazolin&loz; 100 mg/kg per 24 h IV in 3 equally divided doses for &ge;6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         or",
"        </strong>",
"       </p>",
"       <p>",
"        Vancomycin&sect;&yen; 40 mg/kg per 24 h IV in 2 or 3 equally divided doses for &ge;6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         plus",
"        </strong>",
"       </p>",
"       <p>",
"        Rifampin 20 mg/kg per 24 h IV or PO in 3 equally divided doses for &ge;6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         plus",
"        </strong>",
"       </p>",
"       <p>",
"        Gentamicin&Dagger; 3 mg/kg per 24 h IV or IM in 3 equally divided doses for 2 wks",
"       </p>",
"      </td>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        <strong>",
"         One of the following:",
"        </strong>",
"       </p>",
"       <p>",
"        Oxacillin or cloxacillin or flucloxacillin 12g per 24 h IV in 4 to 6 equally divided doses for &ge;6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         or",
"        </strong>",
"       </p>",
"       <p>",
"        Vancomycin&sect; 30 mg/kg per 24 h IV in 2 equally divided doses for &ge;6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         plus",
"        </strong>",
"       </p>",
"       <p>",
"        Rifampin&Delta; 1200 mg per 24 h IV or PO in 2 equally divided doses for &ge;6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         plus",
"        </strong>",
"       </p>",
"       <p>",
"        Gentamicin&bull; 3 mg/kg per 24 h IV or IM in 2 or 3 equally divided doses for the first 2 wks",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Oxacillin-resistant strains",
"      </td>",
"      <td class=\"subtitle2_left\">",
"       Oxacillin-resistant strains",
"      </td>",
"      <td class=\"subtitle2_left\">",
"       Methicillin resistant strains",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        Vancomycin&yen; 30 mg/kg per 24 h IV in 2 equally divided doses for &ge;6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         plus",
"        </strong>",
"       </p>",
"       <p>",
"        Rifampin 900 mg per 24 h IV or PO in 3 equally divided doses for &ge;6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         plus",
"        </strong>",
"       </p>",
"       <p>",
"        Gentamicin&Dagger; 3 mg/kg per 24 h IV or IM in 2 or 3 equally divided doses for 2 wks",
"       </p>",
"      </td>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        Vancomycin&yen; 40 mg/kg per 24 h IV in 2 or 3 equally divided doses for &ge;6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         plus",
"        </strong>",
"       </p>",
"       <p>",
"        Rifampin 20 mg/kg per 24 h IV or PO in 3 equally divided doses for&ge;6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         plus",
"        </strong>",
"       </p>",
"       <p>",
"        Gentamicin&Dagger; 3 mg/kg per 24 h IV or IM in 3 equally divided doses for 2 wks",
"       </p>",
"      </td>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        Vancomycin&yen; 30 mg/kg per 24 h IV in 2 equally divided doses for &ge;6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         plus",
"        </strong>",
"       </p>",
"       <p>",
"        Rifampin&Delta; 1200 mg per 24 h IV or orally in divided doses for &ge;6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         plus",
"        </strong>",
"       </p>",
"       <p>",
"        Gentamicin&bull; 3 mg/kg per 24 h IV or IM in 3 equally divided doses for first 2 wks",
"       </p>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     PVE: prosthetic valve endocarditis; h: hours; IV: intravenously; IM: intramuscularly; PO: orally; wks: weeks",
"     <br>",
"      * Penicillin G 24 million units per 24 h IV in 4 to 6 equally divided doses may be used in place of nafcillin or oxacillin if strain is penicillin susceptible (MIC &le;0.1 &micro;g/mL) and does not produce &beta;-lactamase.",
"      <br>",
"       &bull; Clinical benefit of gentamicin not formally established; remains recommended for PVE. In adults aminoglycosides are dosed based on ideal body weight. Renal function and serum gentamicin concentrations should be monitored at least once per week. When given in three divided doses, pre-dose (trough) concentrations should be &lt; 1 &micro;g/mL and post-dose (peak, 1 h after inection) concentrations should be between 3-4 &micro;g/mL.",
"       <br>",
"        &Delta; Rifampin is believed to be significant in PVE as it may help eradicate bacteria attached to foreign material. It should always be used in combination with another effective antistaphylococcal drug (ideally two active agents) to minimize risk of treatment emergent resistance. Rifampin increases hepatic clearance of warfarin and other drugs.",
"        <br>",
"         &loz; For penicillin-allergic, nonanaphylactoid type patients. Consider skin testing for questionable history of immediate-type hypersensitivty to &beta;-lactams; vancomycin should be used in these cases.",
"         <br>",
"          &sect; Vancomycin therapy only recommended for patients allergic to penicillins or cephalosporins.",
"          <br>",
"           &yen; Vancomycin dose adjusted for peak level (1 h after infusion) of 30-45 &micro;g/mL and trough level of 15-20 &micro;g/mL. In adults vancomycin is dosed based on actual body weight.&nbsp;The dose may need to be increased beyond 30 mg/kg actual body weight and frequency may need to be increased to 3 equally divided doses.",
"           <br>",
"            &Dagger; If organism is gentamicin resistant, an alternative drug such as another aminoglycoside (eg, amikacin), a fluoroquinolone, or another antimicrobial to which the organism is susceptible may be substituted (see text).",
"           </br>",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     1. Baddour, LM, Wilson, WR, Bayer, AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the committee on rheumatic Fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American heart association--executive summary: endorsed by the infectious diseases society of America. Circulation 2005; 111:3167.",
"     <br>",
"      2. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009; 30:2369.",
"      <br>",
"       3. Liu, Catherine et al Clinical Practice guidelines by the Infectious Disease Society of America for the Treatment of Methicillin- Resistant Staphylococcus aureus Infections in Adults and Children. CID 2011; 52; 285-292.",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_61_9182=[""].join("\n");
var outline_f8_61_9182=null;
var title_f8_61_9183="Contents: Endocrine tumors";
var content_f8_61_9183=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/56/1934\">",
"       Endocrinology and Diabetes",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Endocrine tumors",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Endocrine tumors",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Adrenal tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/13/5338\">",
"           Approach to the patient with hypertension and hypokalemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/1/37911\">",
"           Clinical features of primary aldosteronism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/5/22618\">",
"           Clinical features, diagnosis, and management of von Hippel-Lindau disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/48/22282\">",
"           Epidemiology and clinical manifestations of Cushing's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/31/31225\">",
"           Establishing the cause of Cushing's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/25/21913\">",
"           Establishing the diagnosis of Cushing's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/0/3081\">",
"           Medical therapy of hypercortisolism (Cushings syndrome)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/63/1016\">",
"           Overview of the treatment of Cushing's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/26/17834\">",
"           Primary therapy of Cushing's disease: Transsphenoidal surgery and pituitary irradiation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/8/18569\">",
"           The adrenal incidentaloma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/51/40762\">",
"           Treatment of adrenocortical carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/16/40199\">",
"           Treatment of primary aldosteronism",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Carcinoid tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/11/12472\">",
"           Carcinoid heart disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/60/969\">",
"           Clinical characteristics of carcinoid tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/63/9206\">",
"           Clinical features of the carcinoid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/8/11400\">",
"           Diagnosis of the carcinoid syndrome and tumor localization",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/61/39897\">",
"           Treatment and surveillance of non-metastatic carcinoid tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/31/16888\">",
"           Treatment of the carcinoid syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Metastatic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/30/43496\">",
"           Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/32/6665\">",
"           Metastatic gastroenteropancreatic neuroendocrine tumors: Presentation, prognosis, imaging, and biochemical monitoring",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/46/39658\">",
"           Metastatic gastroenteropancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Multiple endocrine neoplasia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/42/8872\">",
"           Approach to therapy in multiple endocrine neoplasia type 2",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/16/22794\">",
"           Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/14/43240\">",
"           Multiple endocrine neoplasia type 1: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/49/17174\">",
"           Multiple endocrine neoplasia type 1: Definition and genetics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/61/38871\">",
"           Multiple endocrine neoplasia type 1: Treatment",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pancreatic endocrine tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/57/18330\">",
"           Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine tumors (islet-cell tumors)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/5/22618\">",
"           Clinical features, diagnosis, and management of von Hippel-Lindau disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/10/14504\">",
"           Clinical manifestations and diagnosis of Zollinger-Ellison syndrome (gastrinoma)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/35/22071\">",
"           Diagnostic dilemmas in hypoglycemia: Illustrative cases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/57/31640\">",
"           Glucagonoma and the glucagonoma syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/30/12777\">",
"           Insulinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/51/6968\">",
"           Management and prognosis of the Zollinger-Ellison syndrome (gastrinoma)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/34/3623\">",
"           Somatostatinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/59/16311\">",
"           The VIPoma syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Parathyroid tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/19/1338\">",
"           Clinical manifestations of primary hyperparathyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/26/5545\">",
"           Diagnosis and differential diagnosis of primary hyperparathyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/47/8954\">",
"           Management of primary hyperparathyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/23/13688\">",
"           Parathyroid carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/28/40387\">",
"           Parathyroid cysts",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/41/30361\">",
"           Pathogenesis and etiology of primary hyperparathyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/60/18377\">",
"           Preoperative localization for parathyroid surgery in patients with primary hyperparathyroidism",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pituitary tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/3/30776\">",
"           Causes and clinical manifestations of acromegaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/18/29992\">",
"           Causes, presentation, and evaluation of sellar masses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/61/22489\">",
"           Clinical manifestations and diagnosis of gonadotroph and other clinically nonfunctioning pituitary adenomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/4/43076\">",
"           Diagnosis of acromegaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/28/41413\">",
"           Diagnosis of hypopituitarism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/34/41510\">",
"           Management of lactotroph adenoma (prolactinoma) during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/20/327\">",
"           Thyrotropin (TSH)-secreting pituitary adenomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/9/7322\">",
"           Treatment of acromegaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/41/8857\">",
"           Treatment of gonadotroph and other clinically nonfunctioning adenomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/52/31561\">",
"           Treatment of hyperprolactinemia due to lactotroph adenoma and other causes",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Thyroid tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/10/23721\">",
"           Anaplastic thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/47/23288\">",
"           Chemotherapy and immunotherapy for medullary thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/43/28345\">",
"           Chemotherapy for differentiated thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/16/14599\">",
"           Clinicopathologic staging of differentiated thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/4/4165\">",
"           Exogenous hyperthyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/17/39191\">",
"           External beam radiotherapy in the treatment of thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/21/9560\">",
"           Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/23/38263\">",
"           Medullary thyroid cancer: Treatment and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/15/8440\">",
"           Overview of papillary thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/17/44313\">",
"           Overview of the management of differentiated thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/49/1818\">",
"           Radiation-induced thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/13/34010\">",
"           Radioiodine treatment of differentiated thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/39/37496\">",
"           Serum thyroglobulin in the management of differentiated thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/30/13799\">",
"           Struma ovarii",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/6/41064\">",
"           Surgical treatment of differentiated thyroid cancer",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-3BEECB8617-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f8_61_9183=[""].join("\n");
var outline_f8_61_9183=null;
